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Abstract 
Solid tumours became malignant when cancer cells invade the surrounding tissues, 
becoming prone to intravasate blood and lymph vessels and to metastasize. In solid 
tumours, tumour-associated macrophages (TAMs) and regulatory T cells (Tregs) are 
reported to favour tumour progression. However, in colorectal cancer (CRC) their 
intratumour infiltration often correlates with good prognosis. Depending on the tumour 
microenvironment, TAMs may polarize into a pro- or an anti-inflammatory profile, modulating 
cancer cell activities and participating in tumour progression. On their turn, Tregs may steer 
macrophage differentiation, modulating macrophage inflammatory profile and functions 
within the tumour microenvironment. 
This study aims to elucidate how TAM-CD4+CD25+ Treg crosstalk affects 
macrophage phenotype, clarifying the role of Treg-educated macrophages on cancer cell 
invasion, as well as dissecting the underlying invasion-related pathways. Therefore, 
macrophage precursors and CD4+CD25+ T cells were co-cultured at 1:1 and 2:1 ratios, for 
3 or 7 days. The monocyte-macrophage profile was then assessed through the analysis of 
specific cell surface receptor expression and cytokine secretion. The impact of CD4+CD25+ 
T cells-educated macrophages on RKO and SW620 CRC cell invasion was evaluated 
through 3D-matrigel-invasion-assays and through analysis of the matrix metalloproteinases 
(MMPs) proteolytic profile. Phosphorylation of epidermal growth factor receptor (EGFR) and 
of its downstream regulators was also evaluated as part of the invasion-related pathway. 
Furthermore, FoxP3-positive cell infiltration on human CRC specimens was characterized 
by immunohistochemistry.  
Our results evidenced that CD4+CD25+ Treg-educated macrophages lost CD80 
maintaining the expression of CD163 and displaying a mixed pro- and anti-inflammatory 
cytokine secretion profile. Only RKO cell invasion was significantly promoted by soluble 
factors produced by macrophages and macrophage/CD4+CD25+ Treg co-cultures, but not 
by Tregs alone. At 2:1 ratio co-cultures, macrophage pro-invasive properties were 
enhanced. This effect was concomitant with increased pro-MMP9 activity and with the 
activation of EGFR (at the residue Y1086). In addition, using histopathological sections 
derived from human CRC specimens, we observed that FoxP3-positive cells infiltrate 
preferentially at the tumour nest and at the invasive front. 
In conclusion, our in vitro results suggest that CD4+CD25+ T cells modulate 
macrophages toward a more anti-inflammatory profile and that, at 2:1 ratio, they promoted 
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macrophage pro-invasive activities. The higher FoxP3 infiltration found at the tumour nest 
and at the invasive front of CRC patient surgical resections are supported by previous 
reports. In the future, we intent to cross CRC FoxP3+ subpopulation characterization and 
TAMS differentiation profile with patients’ clinicopathological information. This research will 
elucidate the modulatory role of Tregs on macrophage pro-tumour properties, contributing 
to the design of novel therapeutic strategies targeting macrophages and/or Tregs.  
 
Keywords: Tumour microenvironment; M1-like pro-inflammatory macrophages; M2-like anti-
inflammatory macrophages; Regulatory T cells; Colorectal cancer cell invasion; Invasion-
related EGFR pathway; Matrix metalloproteinases 
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Resumo 
Os tumores sólidos tornam-se malignos quando as células tumorais ultrapassam os limites 
dos tecidos, tornando-se capazes de entrar nos vasos sanguíneos e linfáticos e metastisar. 
Nos tumores sólidos, os macrófagos associados ao tumor (TAMs) e os linfócitos T 
reguladores (Tregs) estão descritos como promotores da progressão tumoral. No entanto, 
no cancro colorretal (CRC) a sua elevada infiltração intratumoral está geralmente associada 
a bom prognóstico. De acordo com o microambiente tumoral, os macrófagos podem 
diferenciar-se em pró- ou anti-inflamatórios, modelando a atividade das células tumorais e 
participando na progressão tumoral. Por sua vez, os Tregs podem modelar a diferenciação 
dos macrófagos, modelando o seu perfil inflamatório e as suas funções dentro do 
microambiente tumoral. 
Com este projeto pretende-se elucidar como é que a interação TAM-CD4+CD25+ 
Treg afeta o fenótipo dos macrófagos, regulando a sua capacidade de estimular a invasão 
das células tumorais, bem como identificar as vias de sinalização envolvidas nessa 
atividade. Para tal, os precursores dos macrófagos (monócitos) e as células T CD4+CD25+ 
foram co-cultivados nos rácios 1:1 e 2:1, durante 3 ou 7 dias. O perfil de diferenciação 
monócito-macrófago foi assim caraterizado através da análise da expressão de recetores 
celulares de membrana específicos e da produção de citocinas. O impacto dos macrófagos, 
diferenciados na presença de células T CD4+CD25+, na invasão das linhas colorectais RKO 
e SW620 foi avaliado por ensaios de invasão 3D em Matrigel e por análise do perfil 
proteolítico de metaloproteases da matriz (MMPs). A fosforilação do recetor do fator de 
crescimento epidérmico (EGFR) e dos seus reguladores a jusante foram avaliadas, como 
parte de uma via de sinalização associada à invasão. Por último, a infiltração de células 
FoxP3 positivas nos tumores de doentes com cancro colorectal foi caraterizada por 
imunohistoquímica. 
Os nossos resultados demonstram que os macrófagos diferenciados na presença 
de células T reguladoras CD4+CD25+ perderam a expressão de CD80, mantendo a 
expressão de CD163 e apresentando um perfil inflamatório misto com secreção de citocinas  
pró- e anti-inflamatórias. Os macrófagos e as co-culturas de macrófagos/CD4+CD25+ Tregs, 
mas não as Tregs sozinha, produziram fatores solúveis que estimularam apenas a invasão 
das células RKO. No entanto, a capacidade pró-invasiva dos macrófagos foi maior no rácio 
2:1. Este efeito foi concomitante com o aumento da atividade da pró-MMP9 e da ativação 
do EGFR (no resíduo Y1086). Recorrendo a cortes histopatológicos provenientes de 
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amostras de pacientes com cancro colorrectal, observámos que as células FoxP3-positivas 
estão preferencialmente infiltradas na região intratumoral e na frente invasiva. 
Concluindo, os nossos resultados in vitro sugerem que as células T CD4+CD25+ 
modelam os macrófagos para um perfil mais anti-inflamatório e que, no rácio 2:1, promovem 
as propriedades pró-invasivas dos mesmos. O nível elevado de células FoxP3 positivas, 
encontradas no centro do tumor e na frente invasiva de recidivas cirúrgicas de pacientes 
com CRC, está de acordo com a literatura. No futuro, pretendemos cruzar a caracterização 
das populações FoxP3+ com o perfil de diferenciação dos macrófagos nas amostras de 
CRC e com a informação clinico-patológica dos pacientes. Esta investigação permitirá 
elucidar o papel Tregs na modelação das propriedades pró-tumorais dos macrófagos, 
contribuindo para o planeamento de novas estratégias terapêuticas que tenham como alvo 
os macrófagos e/ou os Tregs.  
  
Palavras-chave: Microambiente tumoral; Macrófagos pró-inflamatórios tipo-M1; Macrófagos 
anti-inflamatórios tipo-M2; Linfócitos T reguladores; Invasão das células de cancro 
colorretal; Invasão mediada pela via do EGFR; Metaloproteases da matriz. 
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Introduction 
1. Cancer 
Cancer is a progressive disease that occurs by a multistep regulated process. Typically, it 
arises from a series of mutations and epigenetic alterations that encompass gain of function 
of oncogenes and loss of function of tumour suppressor genes. These series of genetic 
changes confer growth advantages to proliferating cells and drive normal cells to transform 
into a neoplasic state. The progression of solid malignancies is reflected in the genetic 
heterogeneity of tumour cell subpopulations that share a common genetic background within 
a tumour1,2. In fact, only 10% of cancers are linked to germline mutations while the vast 
majority are caused by somatic mutations and environmental factors3. 
 
1.1. Colorectal Cancer 
1.1.1. Epidemiology 
Colorectal cancer (CRC) is the third cause of cancer-related death worldwide4 and one of 
the most frequent and deadliest cancer in Portugal (Globocan, 2012), being a major health 
concern in industrialized and developed countries. Moreover, its incidence is increasing in 
developing countries, while remaining low in less-developed countries5. Environmental risk 
factors such as an inadequate dietary pattern, obesity, tobacco-smoking, excessive alcohol 
intake and sedentarism are considered to increase CRC risk6. These environmental factors 
have been associated with intestinal microbiota alterations and modifications on crucial 
molecular pathways related to CRC tumourigenesis5. Besides dietary and lifestyle factors, 
inherited and somatic mutations, epigenetic changes, as well as chronic intestinal 
inflammation have also prominent roles in CRC occurrence5. 
 Despite advances in CRC diagnosis, knowledge of novel biomarkers and therapies, 
many patients with advanced or metastatic disease, or with local recurrence following 
primary tumour resection, will still die from this disease7. This stands out the need for early 
detection, diagnosis and more effective non-invasive treatments. 
 
1.1.2. Pathogenesis 
The molecular basis underlying the progression of CRC is still subject of intense research.  
Typically, CRC is driven by the gradual accumulation of genetic mutations and epigenetic 
modifications. These modifications induce the activation of oncogenes or loss of function of 
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tumour suppressor genes in proliferating cells, driving the neoplastic process9. Histological 
changes which result in the transition from normal colon mucosa to adenomas and from 
adenomas to invasive carcinomas may them occur8.  
The bulk of CRC cases are sporadic (80%) and result from somatic mutations arising 
during patients’ lifetime. The other 20% have a hereditary component, frequently associated 
with the hereditary nonpolyposis colorectal cancer syndrome (HNPCC or Lynch syndrome) 
and the familial adenomatous polyposis (FAP), and arise from subtle germ-line mutations10. 
In general, the earliest and most common mutation in CRC is the inactivation of 
adenomatous polyposis coli (APC), a tumour-suppressor gene. Consequently, there is an 
overactivation of the wingless-type(Wnt)/β-catenin signalling pathway, favouring transcription 
of tumour-promoting genes and cell growth. This mutation underlies the FAP cases, as well 
as 70–80% of all sporadic CRCs, being frequently found in the aberrant crypt focus (ACF), 
the first identifiable lesion in CRC formation10. 
Subsequent mutations in other genes, most prominently K-RAS, P53 and TGFBRII, 
are related to colon carcinogenesis. The proto-oncogene Kirsten rat sarcoma (K-RAS) 
encodes highly conserved proteins involved in signal transduction. By overactivation of the 
Raf-mitogen-activated protein Kinase (RAF/MAPK), JNK and phosphatidylinositol 3-kinase 
(PI3K) pathways11, K-RAS mutations favour carcinoma growth. This is an early mutational 
event that underlies the transition from early to intermediate adenoma and occurs in 37-41% 
of CRCs11. Tumour protein-53 (P53) is a tumour suppressor transcription factor which 
regulates cell-cycle arrest, genomic stability and apoptosis12. When mutated, P53 may foster 
the malignant transition from intermediate adenoma to carcinoma. Progression of CRC can 
also involve alteration of the TGF-β signalling pathways through mutations in type II TGFβ 
receptor (TGFβRII) gene, that occur in 30% of CRCs13, or in members of these pathways 
namely in SMAD4/2. Genetic mutations in TGF-β signalling are frequently associated with 
microsatellite instability (MSI). MSI, characterized by insertion and deletion in repetitive DNA 
sequences due to the failure of DNA mismatch repair (MMR) mechanisms, gives rise to 15% 
of sporadic CRC and is highly associated with the HNPCC syndrome. 
Epigenetic mechanisms, such as DNA methylation of CpG islands and pos-
translational modifications of histones, have also a prominent role in the alteration of  
chromatin conformation and consequently may favour the transcription of genes that 
mediate CRC development14. Furthermore, specific bacterial pathogens as well as gut 
microflora and its metabolites can induce DNA damage, cell apoptosis and pro-inflammatory 
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conditions, thus promoting colon carcinogenesis15. In fact, individuals with inflammatory 
bowel disease (IBD) display an increased incidence of CRC16. 
All of the above mentioned factors can act in concert to promote CRC development 
and malignant progression, ultimately leading to cancer cell spreading and dissemination  to 
distant organs, primarily to the liver17. 
 
2. The tumour microenvironment 
Typically, tumour formation comprises collaborative interactions between neoplastic cells 
and the surrounding host microenvironment. This intercellular communication occurs 
through a complex and dynamic network of cytokines, chemokines and matrix remodelling 
enzymes that will dictate the tumour fate18. In general, when solid tumours emerge, the 
immune system initiates an anti-tumour response that actively eliminates antigen-
expressing tumour cells, characteristic of a T helper (Th)1-like inflammatory response. 
However, over time, tumour cells elicit several changes in the surrounding stroma and 
escape the host response, shifting the immune environment from a Th1- towards a Th2-
type19. In this way, malignant cells can instruct non-malignant stroma elements to support 
and promote tumour growth, survival, spread and even to affect response to treatment20,21. 
Therefore, together with cancer cells, immune cells, fibroblasts, pericytes, extracellular 
matrix (ECM) components, blood and lymphatics vessels constitute the tumour 
microenvironment (TME) (Figure 1)21. The immune infiltrate found at the TME can include 
multiple cell types. These populations can display both pro- and anti-tumour functions and 
can vary in their activation status, density and localization within the tumour22. Macrophages 
and regulatory T cells (Tregs) are key mediators between tumour cells and stroma 
components and are highly represented in most neoplastic tissues, including CRC23,24. The 
complete understanding of the tumour biology encompasses the study of cellular and 
molecular interactions in the TME that will open novel avenues for enhanced therapeutics 
and better clinical outcomes21. 
 
3. Macrophages 
Mononuclear phagocytes play an essential role in innate immunity and regulate adaptive 
responses25. Tissue macrophages derive from embryonic haematopoietic progenitors that 
persist and maintain the macrophage pool into adulthood26. However, in tissues that are 
exposed to microbiota (e.g. skin and gut) or under extensive inflammatory conditions, blood 
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monocytes can differentiate into tissue macrophages 27. Macrophages are highly diverse 
cells capable of undergoing phenotypic switches depending on environmental cues and on 
the milieu found at the tissue site28. Macrophages may undergo a classical M1-like activation 
(stimulated by IFN (interferon), IFN/LPS (lipopolysaccharide) and Toll-like receptor (TLR) 
ligands or an alternative M2-like activation (induced by IL-10, IL-4/IL-13, IL-33, IL-21)29-31. 
These states mirror the Th1/Th2 dichotomy of T cells and represent two extremes of a 
continuum spectrum of activation. M1-like macrophages express high levels of co-
stimulatory receptors for lymphocytes (CD86/CD80, CD40), antigen-presenting molecules 
(MHC-class II such as human leukocytes antigen-D related protein [HLA-DR]) and produce 
high levels of pro-inflammatory cytokines (e.g. interleukin (IL)-6, tumour necrosis factor-
alpha (TNF-α), IL-12, IL-23 and IL-1β). They target infectious agents or damaged cells, 
promoting cytotoxic activities28,29. Alternatively, M2-like macrophages display high 
phagocytic activity, high expression of the hemoglobin-scavenger receptor (CD163) and of 
the mannose receptor (CD206) and secrete anti-inflammatory cytokines (e.g. IL-10 and 
transforming growth factor-beta (TGF-β))29,32. This macrophage subtype contributes to 
Figure 1. The tumour microenvironment. Tumours are highly complex niches composed by tumour cells, host cells such as 
pericytes, immune cells and fibroblasts, vascular network (blood and lymph vessels) and extracellular matrix components. The 
molecular crosstalk established between tumour cells and the surrounding microenvironment dictates tumour fate. Adapted 
from Junttila et al. (2013) Nature Reviews. 
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parasite clearance33, tissue remodelling34, tumourigenesis28,32 and tumour progression35. 
The distinct functional profile of M1/M2 subsets is further reflected in the selective 
recruitment of other immune cells, such as T cells. While M1-like macrophages induce the 
recruitment of helper (Th1 and Th17) and cytotoxic T lymphocytes (CTL), by producing 
CXCL9 and CXCL10, M2-like macrophages recruit Th2 and regulatory T cells (Tregs), by 
releasing CCL17, CCL22 and CCL2436,37. In established tumours, the presence of pro-
inflammatory Th1, Th17 cells and CTL within the tumour is associated with an anti-tumour 
immune response, whereas the presence of Th2 and Tregs is frequently linked to anti-
tumour immune escape38. 
 
3.1. Macrophages and cancer 
In the majority of the solid tumours, macrophages dominantly infiltrate the tumour 
microenvironment and are frequently associated with tumour initiation, progression and 
metastasis (Figure 2)3,39-41. Macrophage-mediated tumourigenesis is tightly related with an 
inflammatory microenvironment, which promotes mutagenesis and growth of tumour cells3. 
In a developing primary tumour, macrophages hamper the adaptive immune system, 
particularly T cells’ response, and promote angiogenesis, tumour cell migration, invasion 
and intravasation39,42. At the metastatic site, macrophages induce tumour cell extravasation, 
survival and growth39. Different subpopulations of macrophages underlie each of these pro-
tumour activities, highlighting these cells as attractive targets for anticancer therapies39.  
Typically, blood monocytes are chemoattracted from the periphery to the tumour site 
by growth factors (colony stimulating factor-1 (CSF-1), vascular endothelial-growth factor 
(VEGF), placental growth factor (PIGF)) and/or by potent chemoattractant chemokines 
(macrophage inflammatory protein-1α [MIP-1α] (CCL3), MIP-1β (CCL4), regulated on 
activation, normal T cell expressed and secreted [RANTES] (CCL5), macrophage-derived 
chemokine (CCL22))40,43,44. Once within the tissues, monocytes differentiate into tumour-
associated macrophages (TAMs) that share functional features with M2-like (anti-
inflammatory) macrophages, reflecting the Th2-like anti-inflammatory response found at the 
tumour site25. M2-like macrophage polarization can be induced by IL-4, released from 
tumour cells or CD4+ T cells42, as well as by tumour cell-derived growth factors, like tumour 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and colony-stimulating factor  
type 1 (CSF1)45. During tumour progression, TAMs levels are maintained by the proliferation 
of recruited monocytes or of resident macrophages and by their retention at the tumour 
site46. 
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3.1.1. Tumour cell survival and growth 
In general, TAMs and lymphocytes produce IL-6, which is described as promoting 
tumourigenesis, tumour cell survival and growth47. The excess of this pro-inflammatory 
cytokine activates the transcription factor signal transducer and activator of transcription 3 
(STAT3)48, one of the major components of cancer-related inflammation47. The loss of the 
anti-inflammatory cytokine IL-10, that acts through STAT3, also enhanced carcinogen-
induced tumourigenesis in the intestine15. Increased activation of STAT3 is also linked to 
enhanced tumour cell growth and survival, invasion, metastasis, and modulation of tumour-
promoting T-cell subtypes49. At high concentrations tumour necrosis factor-alpha (TNF-α), 
one of the major mediators of inflammation, is also able to induce tumourigenesis50. 
 
3.1.2. Tumour cell invasion 
The ability of cancer cells to cross tissue boundaries and invade neighbouring areas is what 
confers them malignancy. In breast cancer, macrophages were described as obligate 
partners in cancer cell migration, invasion and metastasis35. Cancer cell-derived CSF1 was 
described to induce macrophage secretion of epidermal growth factor (EGF), which in turn 
activates cancer cell EGF receptor (EGFR), stimulating tumour cell migration and invasion51-
54. Moreover, it was described that macrophages are able to induce an angiogenic switch55 
and that tumour cell intravasation occurred in association with perivascular macrophages52. 
The relevance of this CSF1-EGF loop was further confirmed when ablation of macrophages, 
through depletion of CSF1, decreased circulating tumour cells and metastasis52. Further, 
the use of CSF1R antagonists inhibited the migration of both tumour cells and 
macrophages56. In line with these results, our team described that soluble factors produced 
by human macrophages promoted gastric and colorectal cancer cell invasion, motility, 
migration and proteolysis57. These results were described to be dependent on matrix 
metalloproteinase (MMP)-9 and 2 activities and on the activation of EGFR (at the residue 
Y1086), PLC-γ (phospholipase C-gamma), Gab1 (GRB2-associated binding protein-1), cSrc 
(Cellular Homologue of Rous sarcoma virus protein) and ERK1/2 (Extracellular regulated 
MAP kinase1/2). When EGF was depleted from the medium, macrophage-mediated cancer 
cell invasion and motility was impaired, suggesting EGF as one of the major pro-motile and 
pro-invasive factors produced by macrophages. Further, macrophages also induced 
phosphorylation of Akt (v-AKT murine thymoma viral oncogene homologue), and increased 
RhoA (Ras homolog gene family, member A) and Cdc42 (Cell division cycle protein 42) 
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activity. Interestingly, Akt phosphorylation seemed to be induced independently of EGFR 
activation (Figure 3)57.  
Macrophage are major contributors to tissue and matrix remodelling in tumours, 
being great producers of MMPs57-59 and of other proteolytic enzymes (e.g. osteonectin 
(SPARC)60, cathepsin proteases61). Secreted MMPs degrade the ECM releasing trapped 
pro-invasive, pro-motile and pro-angiogenic factors and opening paths for cell migration62. 
This favours local cancer cell invasion, intravasation into blood/lymph vessels and 
spreading63. Our group demonstrated that IL10-stimulated macrophages are more efficient 
in stimulating gastric and colorectal cancer cell migration, invasion and angiogenesis than 
their LPS-stimulated counterparts. Interestingly, these differences seemed to be related to 
the enhanced MMP-2 and MMP-9 activities of IL-10-stimulated macrophages and not to 
differences in the activation of the EGFR-signalling pathway, which is identical in both 
Figure 2. TAMs facilitate tumour cell survival and growth, migration and invasion, angiogenesis, metastasis and 
immune suppression. TAMs produce cytokines and growth factors (IL-6, low concentrations of TNF-α and EGF) that 
support tumour growth and survival. TAMs produce high levels of MMPs, favouring degradation of extracellular matrix and 
facilitating local tumour cell invasion, blood vessels intravasation and metastatic dissemination. Tumour invasion is tightly 
linked to the CSF1-EGF loop that occurs between macrophages and tumour cells. In addition, TAMs induce neoangiogene 
through the secretion of pro-angiogenic factors, such as VEGF and CXCL8. Additionally, macrophage-mediated immune 
suppression is correlated to their ability to counteract cytotoxic T cell function, through the release of IL-10 and TGF-β, and 
to recruit regulatory T cells (Tregs) through the release of chemokines such as CCL20 and CCL22. Adapted from Marelli et 
al. (2015) Cancer Research Frontiers. 
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macrophage populations58. The process of invasion may also involve macrophage-derived 
TGF-β, that promotes epithelial to mesenchymal transition (EMT)64, a mechanism that 
promotes the invasive and metastatic behaviour of epithelial cancer cells65. 
Yet, the molecular mechanisms that drive cancer cell invasion and metastasis as 
well as the contribution of the cellular and non-cellular components of the tumour 
microenvironment remain poorly understood and constitute still major challenges in the 
cancer research field. 
 
3.1.3. Angiogenesis 
Macrophages increase the density of blood vessels at the tumour site, providing oxygenation 
and nutrients to tumour cells, in a process referred as “angiogenic switch”66. TAMs favour 
neoangiogenesis through the production of angiogenic factors such as VEGF-A, CXCL8, 
PIGF and prokineticin67. The genetic depletion of macrophage VEGF attenuated 
angiogenesis68, while depletion of macrophages impaired tumour angiogenesis which was 
only restored via ectopic overexpression of VEGF69. The combination of increased migration 
and angiogenesis induced by macrophages facilitates cancer cell intravasation, facilitating 
metastasis70.  
 
3.1.4. Immunosuppression 
TAMs suppress the anti-tumour adaptive immune responses. In fact, TAMs can directly 
inhibit the role of effector cells (e.g. natural killer cells [NK], conventional CD4+ T cells 
[Tconvs] and CTL) of the adaptive immune response by expressing the programmed cell 
death protein 1 (PDL1) and the co-stimulatory molecules CD80/CD86, which engage the 
receptor cytotoxic T-lymphocyte antigen 4 (CTLA-4)71 and/or by releasing IL-10 and TGF-
β72. Additionally, TAMs are able to shape the type of leukocyte infiltrate at the tumour site 
through the release of chemokines (e.g., CCL17, CCL18, and CCL22) that will recruit 
immune suppressive cells, such as Tregs42, inhibiting the proliferation and function of 
effector cells and favouring tumour immune escape70. Additionally, M2-like macrophages 
have been implicated in de novo generation and clonal expansion of Tregs, as well as in the 
inhibition of IL-17-producing CD4+ T cells (Th17), further assisting the formation of a high 
anti-inflammatory microenvironment. 
 
 
 
FCUP 
Elucidating the role of macrophage and CD4+CD25+ regulatory T cells on colorectal cancer cell invasion
23 
 
 
3.2. Macrophages in colorectal cancer 
In line with the findings mentioned above, TAMs infiltration is frequently associated with poor 
prognosis73. However, in CRC the prognostic value of such infiltration is still contradictory74. 
While some studies associate massive macrophage infiltration with poor prognosis75,76 
others correlate high density of TAMs with improved outcome73,77,78. However, some of these 
studies lack TAMs phenotypic characterization77, solely using a lineage-macrophage marker 
(e.g. CD68), without discriminating macrophage subpopulations. Due to the plasticity of 
these cells, one critical aspect in macrophage characterization is the discrimination between 
Figure 3. Model proposal for the macrophage-mediated invasion pathway. Soluble factors produced by macrophages, 
namely EGF, lead to EGFR phosphorylation in cancer cells. By siRNA experiments, EFGR-interacting partners such as Gab1 
and PLC-y were demonstrated to be required for macrophage-mediated cancer cell invasion. Other molecules such as cSrc, 
ERK, Akt, and the small GTPAses Cdc42 and RhoA were demonstrated to be phosphorylated/activated. Silencing of EGFR 
demonstrated that macrophage-mediated cancer cell c-Src and ERK but not Akt occur downstream of EGFR signalling. 
Dashed arrows indicate putative interactions described in the literature. Closed circles indicate inactivation by pharmacological 
inhibitors. Unshaded rectangles indicate transient knocked-out expression by siRNAs. Black circles indicate increased protein 
phosphorylation. Elipses indicate increase in the GTP-bound form of the protein. Adapted from Cardoso et al (2013) 
Oncogene. 
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M1 and M2 subpopulations79. Several studies use inadequate M1- or M2-like markers78,80. 
For instance, inducible nitric oxide synthetase 2 (iNOS2), used as a M1-like marker78, was 
described to be a specific marker for these macrophages in mice, but not in humans. Further, 
the use of HLA-DR, frequently used as a M1-like marker, was also questioned80. 
Nevertheless, TAMs location at different tumour regions appears to be crucial for prognostic 
prediction, since accumulation of TAMs at the tumour invasive front, a region less affected 
by cancer cells, was associated with increased patients’ disease-free survival73,77. Our group 
is assessing macrophage infiltration in CRC specimens and has observed interesting 
results: stronger infiltration of M1-like macrophages (positive for CD80) at normal colonic 
mucosa in contrast to M2-like (positive for CD163) macrophage accumulation at normal 
colonic mucosa, tumour nest and invasive front (MLPinto, unpublished data). Future work 
includes correlation of these results with the clinicopathologic data of patients, to evaluate 
possible clinical associations. 
 
4. Regulatory T cells 
Regulatory T cells (Tregs) are known to develop and maintain peripheral self-tolerance 
(recognition and unresponsiveness to self-constituents), and control immune responses to 
non-self-antigens81,82. 
Tregs derive from the thymus83 and from thymic emigrants that were induced into 
Tregs in the periphery84 and include  CD4+, CD8+ T cells and CD4-CD8- double negative 
subtypes85. The majority of Tregs comprise a small subset of CD4+ T lymphocytes in mice 
and human (5-10%)86 and are characterized by high cell surface expression of the 
interleukin-2 receptor α-chain (IL-2Rα) (CD25)86, required for Treg survival and IL-2 
absorption87 and by the expression of Forkhead box protein 3 (Foxp3)88. FoxP3 is an 
essential Treg lineage-specifying transcription factor required for Treg development and 
suppressive competence89. Among other factors, demethylation of the Treg-specific 
demethylated region (TSDR), a FoxP3 locus, was shown to be crucial to maintain stable and 
high the expression of FoxP390. Tregs molecular signature requires additional nuclear 
factors and is dependent on several molecules and signals such as lL-2, TGF-β, and co-
stimulatory molecules such as CD28, triggered by its ligands CD80/CD86, expressed in 
APCs91. Treg cells display a distinct T cell receptor (TCR) repertoire, with increased affinity 
with self-antigen compared with that of Tconvs92. 
Currently, FoxP3 is one of the selected markers to identify Tregs, but its nuclear 
localization requires permeabilization of cellular and nuclear membranes, inhibiting the 
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isolation of viable Tregs93. Although the majority of FoxP3-expressing CD4+ T cells are 
considered to be suppressive Tregs in mice, CD4+FoxP3+ T cells in humans display a 
heterogeneous phenotype and function92. For instance, CD4+CD25- Tconvs can transiently 
upregulate the expression FoxP3 without acquiring suppressive competence94. 
Furthermore, not all CD4+CD25+FoxP3+ T cells in PBMCs possess suppressive 
competence95. It is imperative to identify distinct human FOXP3+ subpopulations to better 
understand Treg subpopulations in normal and disease states and to specifically target them 
to control pathological immune responses. To delineate FoxP3+ T cell populations several 
cell surface molecules were investigated: IL-7 receptor α-chain (CD127), glucocorticoid 
induced TNFR family-related protein (GITR), CTLA-4, CD45RA (or CD45RO) and sialyl 
Lewis x (CD15s)92,96-98. These markers are expressed at different levels and reflect 
differential functional stages of the heterogeneous Treg population. However, these markers 
still carry some drawbacks and have to be used in concert. For instance, CD25 expression 
forms a continuum being difficult to accurately define a CD25high population and can be 
upregulated by Tconvs92. 
Miyara et al.95, described that CD4+CD25+FoxP3+ T cells can be divided into three 
phenotypically and functionally distinct subpopulations: 1) naïve or resting Tregs as 
CD25+CD45RA+FOXP3low (rTreg), 2) effector or activated Tregs as CD25highCD45RA-
FOXP3high (aTreg), and 3) non-suppressive CD4+ T cells as CD25+CD45RA-FOXP3low 
(FOXP3+ non-Treg). In vitro and in vivo studies demonstrated that rTregs proliferate upon 
TCR stimulation and convert into terminally differentiated aTregs, which are hyporesponsive 
and highly apoptotic after activation and suppression. On the other hand, non-Tregs 
abundantly secrete pro-inflammatory cytokines, such as IL-17, are less active in FoxP3 
expression and do not suppress Tconvs proliferation in vitro95. In addition, in vitro and in vivo 
studies demonstrated that previously suppressive FoxP3+ Tregs lost their suppressive ability 
under Th1 and Th17-polarizing environments and acquire the ability to produce pro-
inflammatory cytokines99. Altogether these data show the heterogeneity but also the 
plasticity of Treg populations in different microenvironments. 
Additionally, Tregs can also be induced (iTregs) from Tconvs/naïve via TCR 
stimulation in the presence of IL-10 and TGF-β, generating Type-1 regulatory T cells (Tr1) 
and Th3, respectively. Tr1 express high levels of IL-10 in the absence of FoxP3 
expression100; Th3, are a TGF-β-secreting Treg subset characterized by low IL-10 and 
intermediate levels of FoxP3 expression101. 
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Tregs are able to suppress activation, proliferation and function of distinct immune 
cells, including CD4+ and CD8+ T lymphocytes, NK and NKT cells, and antigen-presenting 
cells (APCs) (Dendritic cells [DCs] and macrophages) and B cells70,102. Treg-mediated 
suppression can occur by cell-to-cell contact or in a cytokine dependent manner, via multiple 
mechanisms. The activated mechanisms may depend on the local microenvironment, the 
suppressed target cell or on the state of activation of Tregs (Figure 4)102. Tregs inhibit T cells 
through release of inhibitory cytokines, such as IL-35, IL-10 or TGF-1β102,103, but a direct cell 
contact between Tregs and Tconvs is required118,119. In turn, these inhibitory cytokines 
induce other types of Tregs from CD4+ T cells104. The high levels of IL-2R chain at Tregs 
surface can lead to competitive consumption of IL-2, scavenging it from other T cells and 
consequently inhibiting their proliferation; Tregs can generate and secrete adenosine, 
degrade tryptophan and transfer cAMPs to other T cells, leading to their metabolic 
disruption105. Via perforin and granzyme-dependent pathways Tregs can directly elicit 
effector T cell apoptosis. Finally, Tregs can indirectly affect Tconvs by hampering APCs 
function. CTLA-4, highly expressed at the surface of Tregs, binds to co-stimulatory 
molecules, such as CD80/CD86 from the surface of APC, leading to their removal106. The 
direct interaction established between Tregs and APC prevents the stable contacts between 
APC and the co-stimulatory molecule CD28 of CD4+ T cells, inhibiting T cell activation106. 
 
4.1. Tregs in cancer 
Tregs are mediators of peripheral tolerance to self-antigens and innocuous 
environmental antigens81. Tumour-associated antigens are modified or aberrantly 
expressed self-antigens. It is, therefore, expected that Tregs are the major precursors of 
tumour immune evasion107. In fact, Tregs were described to recognize a broad range of 
tumour-associated self-antigens and to suppress the response of tumour-antigen-specific 
effector T cells108. Additionally, Tregs have more self-reactive TCR repertoires and thus 
present higher ability to recognize self-tumour antigens than other CD4+ T cells92. 
Previous studies have reported that during tumour initiation Tregs are enriched in 
the tumour tissue and in advance-stage disease their number increase systemically, in 
comparison to healthy individuals109. Tregs accumulate at the tumour microenvironment by 
recruitment, expansion and de novo generation. Tumour cells and stroma components 
produce and secrete several factors that are chemoattractants for Tregs, recruiting them to 
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the tumour site. For instance, in colorectal cancer, CCL20 secreted by TAMs induces the 
recruitment of CCR6+ nTreg cells110 and, in ovarian cancer, TAMs are described to secrete 
CCL22 that mobilizes CCR4+ nTreg cells111. After recruitment, Tregs are activated and 
expanded in the tumour. The high levels of TGF-β and IL-10 produced by tumour cells and 
TAMs favour pre-existing Tregs clonal expansion101. Furthermore, effector T cells were 
proposed to secret IL-2 that could induce the proliferation of Tregs112. The combined 
presence of TGF-β and IL-10 with DC or TAMs promotes the conversion of naïve or 
conventional T cells into suppressive Tregs, Th3 and Tr1113,114. Prostaglandin E2 (PGE2), 
indoleamine 2,3-dioxygenase (IDO), and TGF-β derived from the tumour have also been 
correlated with the conversion of iTregs from Tconvs/naïve115,116.   
The immunosuppressive role of Tregs was also indirectly correlated with metastatic 
advantages117,118. In breast cancer models, recruitment of Tregs to the primary tumour, 
increased CTL and NK cells’ apoptosis and metastasis. Additionally, in the same model, the 
suppression of lung metastasis was accompanied by decrease of CD4+CD25+ T cells in the 
Figure 4. Mechanisms of Treg-mediated suppression. Tregs suppress directly or indirectly conventional T cells (Tcon) via 
different mechanisms, depending on the local immune environment, in the target cell or even according to Tregs status. Tregs 
secrete immunosuppressive adenosine or transfer cAMP to Tconvs, produce immunosuppressive cytokines (IL-10, TGF-β, IL-
35), suppress Tconvs by IL-2 consumption or induce effector cell death via granzyme and perforin. Furthermore, Tregs can 
suppress Tconvs indirectly by downregulating costimulatory molecules on APCs (such as DCs) via CTLA-4. Adapted from 
Schmidt et al. (2012), Frontiers in immunology. 
 
FCUP 
Elucidating the role of macrophage and CD4+CD25+ regulatory T cells on colorectal cancer cell invasion
28 
 
primary tumour121. Additionally, systemic Treg depletion in patients induced regression of 
melanoma metastases120.  
 
4.1.1. Prognostic value of Tregs in colorectal cancer 
The infiltration of Tregs into tumours has been reported to be associated with an 
unfavourable outcome in several human cancers, such as ovarian119, breast, 
gastrointestinal, lung, liver, pancreatic cancer and melanoma120. Contrarily, in CRC the 
results are controversial with high densities of FoxP3+ Tregs mostly correlating with 
favourable outcomes121-125 Tregs infiltrate preferentially at the tumour nest (TN)122,125. In a 
cohort of 967 CRC specimens, high density of FoxP3+ T cells at the TN was associated with 
better prognosis, whereas their accumulation at the surrounding healthy tissues was 
associated with worse prognosis122. Similar results were found by Frey et al. in a cohort of 
1420 patients, where high FoxP3 infiltration at tumour site was an independent positive 
predictor of 5-years disease free survival in MMR-proficient patients, but not in MMR-
deficient patients121. Even in a metastatic setting, higher levels of FoxP3+ T cells, within the 
tumour of patients subjected to chemotherapy, was associated with better prognosis126. Ling 
and colleagues demonstrated that high levels of FoxP3+ T cells correlated with a good 
prognosis in patients with low infiltration of CD8+T cells125. Moreover, they described that 
accumulation of FoxP3 at the invasive front and TN alone are correlated with better 
prognosis, bearing strong prognostic information125. Additionally, higher intratumoural 
infiltration of Tregs than IL-17+ T cells were associated with suppressed MMPs activities and 
decreased metastases score in CRC cancer upon resection127. Nevertheless, Treg-
mediated suppression also involves interactions with APCs, and the prognostic role of the 
balance between macrophages and/or DCs and Tregs has not yet been performed in a CRC 
context. 
The role of FoxP3+ tumour-infiltrating lymphocytes in CRC may depend on the 
immune response found at the tumour. If the tumour microenvironment is infiltrated with 
immune cells that promote tumourigenesis and/or tumour progression, the 
immunosuppressive role of Tregs may be beneficial. However, if a Th1-like response, 
characteristic of a tumour antigen-specific immune response is dominant, the suppression 
by Tregs can be deleterious promoting tumour immune escape and progression128. The 
controversial results of FoxP3 infiltration can be further explained by the phenotypic and 
functional heterogeneity of FOXP3+ T cell subpopulations129. The contribution of each Treg 
subpopulation (rTregs, aTregs and non-Tregs) at CRC microenvironment is still unknown. 
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A higher infiltration of non-Treg, capable of producing pro-inflammatory cytokines, could 
contribute to a better prognosis of FoxP3+ T cells in CRC130. The controversial role of Tregs 
in cancer may also rely on the low inter-study comparability due to the use of different 
techniques, among others. The role and the prognostic significance of FoxP3+ infiltration 
and FoxP3+ subpopulation is still scarce. However, it seems that Tregs exert distinct 
influences at different inflammatory microenvironments, which may be reflected on different 
FoxP3+ subpopulations128. The impact of Tregs in tumour progression may be determined 
by the type and location at the tumours as well as by the balance between Tregs and other 
immune populations within the tumour mass22. It is then imperative to clarify the role of 
FoxP3+ T cells in the tumour microenvironment, so as to adopt adequate different strategies 
to manipulate Tregs, in order to improve patient survival. 
 
5. Macrophage-Treg crosstalk 
By cell-to-cell contact and in a cytokine-dependent way, Tregs exert a suppressive effect on 
monocyte/macrophage activation and effector function131,132. In humans, the inhibitory 
functions of Tregs on monocyte-derived macrophages were provided by in vitro autologous 
co-cultures between CD4+CD25+ T cells and monocytes131. These monocytes displayed a 
resting phenotype, producing lower levels of IFN-, TNF-α and IL-10 than when co-cultured 
with CD4+CD25- T cells. When further challenged with LPS, Treg-educated macrophages 
were inhibited ofproducing IFN-, TNF-α and IL-6 and exhibited downregulation of CD86 
when comparing with control monocytes. The different macrophage activation was reflected 
in the hampered APC function of Treg-educated macrophages131. Later, Tiemessen and 
colleagues132, showed that Tregs steered macrophage differentiation towards an 
immunosuppressive phenotype132, characterized by the upregulation of CD206 and CD163 
and downregulation of HLA-DR and CD86. In addition, Treg-educated monocytes increased 
secretion of CCL18, enhanced phagocytic capacity and displayed a diminished capacity to 
respond to LPS, producing low levels of pro-inflammatory cytokines (IL1-β, IL-6, IL-8 TNF-
α). The authors described that the upregulation of CD163 was dependent on IL-10. 
Contrarily, the upregulation of CD206 was cytokine-independent suggesting the need of cell-
to-cell contact, which was further demonstrated using transwell assays132. Kryczek et al. 
reported a similar suppressive profile on human macrophages cultured with Tregs, but 
further described that the higher levels of IL-10 produced by Treg-educated macrophages 
induced the upregulation of the Tconvs cell inhibitory molecule B7-H4 on monocytes133. In 
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line with these reports, the presence of Tregs after myocardial infarction induced 
macrophages toward an anti-inflammatory profile, contributing to inflammation resolution 
and wound healing135, in a mouse model. In the physiologic intestinal microenvironment, 
commensal microbiota promotes colonic Tregs differentiation, which in turn contribute to the 
immune homeostasis in the colon136. Tregs differentiation is also favoured by colonic DCs 
which repress the expression of LPS response genes, promoting microbiota protection, as 
well as, inhibiting macrophage activation due to hyporesponsiveness to TLR stimulation136. 
Nevertheless, the modulatory role of Tregs on macrophages phenotype and functions in a 
cancer context is still scarce. 
Conversely, macrophages induce Tregs differentiation113,114 and recruitment137, 
extending their population within tumours and maintaining an immunosuppressive 
microenvironment that may favour tumour progression138. Along with cancer cells, TAMs are 
major source of TGF-β and directly induce Tregs by cell-to-cell interaction via membrane 
bound TGF-β137. In a colitis mouse model, macrophage-derived IL-10 was described to 
maintain FoxP3 expression in Tregs139. Further, in an immunocompetent mouse model with 
renal injury, IL-10/TGF-β–modified macrophages attenuated renal inflammation140. The 
suppression of CD4+ T cells by IL-10/TGF-β–modified macrophages induced proliferation 
regulatory T cells from CD4+CD25- T cells and increase Tregs in renal draining lymph 
nodes140. These results highlight the role of anti-inflammatory macrophages in de novo 
generation and recruitment of Tregs. Nevertheless, under pro-inflammatory conditions (e.g. 
rheumatoid arthritis), monocyte-derived IL-6, IFN- and IL-1β was described to induce 
aTregs to produce both pro-inflammatory (IL-17, IFN-, TNF-α) and anti-inflammatory (IL-
10) cytokines, without losing their suppressive functions141. These data indicate that different 
macrophage subsets display distinct roles in the modulation of Tregs’ properties, however 
the exact mechanisms underlying these modulation is still not completely understood. 
Furthermore, it is also likely that different Treg subpopulations could distinctly modulate 
macrophage inflammatory profiles. 
FCUP 
Elucidating the role of macrophage and CD4+CD25+ regulatory T cells on colorectal cancer cell invasion
31 
 
Aim 
Tumours are considered malignant when cancer cells invade the surrounding tissues, 
becoming prone to intravasate vessels and to metastasize. TAMs are considered obligate 
partners in the malignant transformation. Additionally, Tregs, which display 
immunosuppressive properties facilitate tumour immune escape, favouring cancer cell 
invasion. Given the modulatory role of Tregs on macrophage inflammatory phenotype, it is 
likely that Treg-educated macrophages may have enhanced pro-tumour activities. However, 
in CRC the role of TAMs and Tregs is controversial since their intratumoural infiltration is 
often correlated with good prognosis. Also, the influence of Tregs on monocyte/macrophage 
pro-invasive properties is presently unknown. Similarly, the phenotypic and functional profile 
of these immune cell populations and respective subpopulations in a CRC context remains 
to be elucidated.  
Therefore, the main goal of this project is to better understand the role of Tregs on 
macrophages behaviour, uncovering their impact on CRC cell invasion. Specific objectives 
include: 
1) Evaluate the impact of Tregs on monocyte-derived macrophage differentiation; 
2) Assess the role of Tregs-educated macrophages on colorectal cancer cell 
invasion; 
3) Investigate the mechanisms underlying Tregs modulation of macrophage-
mediated cancer cell invasion, such as on MMPs proteolytic activity and the 
activation of the EGFR-invasion related signalling pathway; 
4) Characterize FoxP3+ T cell infiltration in human CRC specimens. 
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Materials and methods 
Cell line culture 
The RKO (CRL-2577) and SW620 (CCL-227) stablished cancer cell lines, derived from 
human colon carcinomas, were obtained from the American Type Culture Collection (ATCC, 
Manassas, VA, USA) in 2012. RKO and SW620 cells were maintained at 37ºC, under a 5% 
CO2 humidified-atmosphere, in complete RPMI1640-GLUTAMAX medium (Invitrogen, 
Merelbeke, Belgium) or in DMEM+F12 medium (Invitrogen), respectively. Media were 
supplemented with 10% fetal bovine serum (FBS) (Lonza, Basel, Switzerland), 100 U/ml 
penicillin and 100 mg/ml streptomycin (Invitrogen). 
 
Immune cells isolation 
Human monocytes and regulatory T cells were isolated from healthy blood donors’ buffy 
coats, provided by the Immunohemotherapy Department, Hospital São João, Porto, 
Portugal. For an autologous setting, the same blood donor was used to isolate CD14+ 
monocytes and CD4+CD25+ T cells. To combine monocyte with BD regulatory T cell isolation 
(BD Biosciences, Madrid, Spain), buffy coats were initially divided. Alternatively, to combine 
monocyte isolation with the StemCell regulatory T cell isolation kit (StemCell Technologies, 
Grenoble, France), peripheral blood mononuclear cells (PBMCs) collected from buffy coats 
were divided. 
 
CD14+ monocyte isolation 
Monocytes were isolated using the Human Monocyte Enrichment Cocktail (StemCell 
Technologies), which consists in a negative selection of CD14+ cells. From our previous 
work using this isolation system, over 80% of isolated monocytes were found to be CD14-
positive57. Briefly, buffy coats were centrifuged at 1200 xg, without brake, for 20 minutes at 
room temperature (RT). The whitish layer containing PBMCs was then collected and used 
to isolate CD14+ monocytes. PBMCs were incubated for 20 minutes under rotation with the 
RosetteSep™ Human Monocyte Enrichment Cocktail (StemCell Technologies), according 
to manufacturer’s instructions. The enriched mixture was diluted (1:1 ratio) in phosphate 
buffered saline (PBS) supplemented with 2% FBS (Lonza), gently layered over equal volume 
of Histopaque®-1077 (Sigma-Aldrich, Madrid, Spain) and centrifuged at 1200 xg, without 
break, for 20 minutes at RT. The interface layer, enriched in human CD14+ monocytes, was 
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collected, washed with PBS and centrifuged at 98 xg, with brake, for 17 minutes at 4ºC. The 
supernatant was discarded and the pellet with the isolated cells were resuspended with 
complete RMPI1640-GLUTAMAX medium supplemented with 10% FBS, 100 U/ml penicillin 
and 100 mg/ml streptomycin. For the in vitro studies, monocytes were seeded in the same 
culture medium, according to the experimental set up.  
 
Human CD4+CD25high T cell isolation 
The Human Regulatory T Lymphocyte Separation Set (BD Biosciences) or the Regulatory 
T cell Isolation Kit (StemCell Technologies) were used to isolate the broadest phenotypic 
variety of Tregs. Isolations consisted in a negative (CD4+) followed by a positive (CD25+) 
selection of cells.  
1. Human Regulatory T Lymphocyte Separation Set (BD Biosciences) 
To isolate PBMCs, blood from buffy coats were gently layered over Histopaque®-1077 and 
centrifuged at 1200 xg, without brake, for 20 minutes at RT. The whitish layer containing 
PBMCs was then collected, washed with PBS, centrifuged at 18 xg for 10 minutes and the 
supernatant discarded. Then, PBMCs were resuspended in the Human Regulatory T 
Lymphocyte Separation Cocktail for 15 minutes at RT. The labelled cells were washed in 1x 
BD IMag™ buffer (1:10 ratio), centrifuged at 300 xg for 8 minutes, and the supernatant 
discarded. For CD4+ T lymphocytes enrichment, cell pellet was resuspended in BD IMag™ 
Streptavidin Particles Plus – DM and incubated for additional 30 minutes at RT. The labelled 
cell suspension was brought to 60x106 cells/mL with 1x BD IMag™ buffer, transferred to 5 
mL round-bottom polystyrene tube (BD Falcon) and placed on the EasySep® magnet for 7 
minutes. The supernatant (enriched fraction) was transferred to a new sterile tube. The 
enrichment step was repeated twice. The tube containing the combined enriched fraction 
was placed on the magnet for 7 minutes and the supernatant was removed to a new tube 
for a twice-enriched fraction containing CD4+ T lymphocytes. For the positive selection of 
CD4+CD25+ T cells, the twice-enriched fraction was centrifuged, as previously, and the cell 
pellet was resuspended in the BD IMag™ Anti-APC Particles – DM and incubated for 30 
minutes at RT. The labelled cell suspension was brought to 60x106 cells/mL with 1X BD 
IMag™ buffer, transferred to 5 mL round-bottom tube and placed on the magnet for 8 
minutes. With the tube on the magnet, supernatant was discarded. After two wash steps, 
the tube was removed from the magnet and isolated CD4+CD25+ T cells were resuspended 
in complete RMPI1640-GLUTAMAX medium supplemented with 10% FBS, 100 U/mL 
penicillin, 100 mg/mL streptomycin and 50 ng/mL anti-CD3 (OKT3, Abcam, UK).  
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2. Regulatory T cell Isolation Kit (StemCell Technologies) 
Buffy coats were centrifuge at 1200 xg, without brake, for 20 minutes at RT. The whitish 
layer containing PBMCs was then collected and used to isolate CD4+CD25+ T cells. PBMCs 
were incubated for 20 minutes under rotation with RosetteSep® Human CD4+ T Cell 
Enrichment Cocktail, following manufacturer’s instructions. The enriched mixture was diluted 
(1:2 ratio) in PBS + 2% FBS, gently layered over Histopaque®-1077 and centrifuged, as 
previously. The interface layer, enriched in CD4+ cells, was collected, washed with PBS + 
2% FBS, centrifuged at 1200 xg, with brake, for 17 minutes at 4ºC and the supernatant was 
discarded. The enriched sample was transferred to a 5 mL round-bottom polystyrene tube 
and incubated under rotation with EasySep® Positive Selection Cocktail, for 15 minutes. 
Then, EasySep® Magnetic Nanoparticles were added to the suspension, for 10 minutes, 
following manufacturer’s instruction. The cell suspension was brought to a volume of 2.5 mL 
with PBS + 2% FBS, resuspended and place into the magnet for 5 minutes. The supernatant 
fraction was then discarded while the magnetically labelled cells remained inside the tube. 
The positively selected cells were resuspended with complete RMPI1640-GLUTAMAX 
medium supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/ml streptomycin and 50 
ng/mL anti-CD3 (Abcam). For the in vitro studies Tregs were seeded in the same culture 
medium. A fraction of CD4+CD25+ T cells was analysed by flow cytometry to evaluate the 
efficiency and purity of the cell separation procedure. Isolation resulted in 77% CD4+CD25+ 
T cells with 94% expressing FoxP3. 
 
Mono-culture of human CD14+ monocytes or of CD4+CD25+ T cells 
Isolated human CD14+ monocytes from two different healthy blood donors were seeded in 
58 cm2 tissue-culture petri dishes (Greiner, Frickenhausen, Germany) at a density of 1x107 
monocytes per plate and maintained at 37ºC, under a 5% CO2 humidified-atmosphere for 
24 hours. Then, monocytes were transferred to three different substrates: 6-well tissue 
culture-treated plates (Falcon, Durham, USA) at a density of 1,2x106 monocytes per well 
(0,13 x106 monocytes/cm2); 6-well tissue culture-nontreated plates at a density of 1,2x106 
monocytes per well (0,13 x106 monocytes/cm2) (Falcon); and 24-well tissue culture-treated 
plates (Falcon) with coverslips (Deckglasser, Lauda-Konigshofen, Germany) at a density of 
5x105 monocytes per well (0,26 x106 monocytes/cm2). Non-treated plates are hydrophobic 
polystyrene surfaces whereas treated plates are hydrophobic polystyrene surfaces that 
where chemically treated to become hydrophilic, usually by increasing their negative charge, 
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in order to improve cell attachment. The initial cell density seeded on 6- and 24-well plates 
relies on previous work performed in our laboratory57,58. Cultures were maintained at 37ºC, 
under a 5% CO2 humidified-atmosphere to allow monocyte to macrophage differentiation for 
3 and 7 days, as commonly performed in macrophage studies. At the third day, the culture 
medium was renewed. Morphology, density and adhesion of cells were examined at the 
third and seventh days, using a Olympus CKX41 (SC30) optical microscope and 
photographed with the anaySYSgetIT, 5.1 Software.  
After CD4+CD25+ T cells isolation with Regulatory T cell Isolation Kit from SC, 
3.6x106 cells from the enriched CD4+ mixture were collected to assess cell purity by FACS. 
In the end of the isolation procedure, CD4+CD25+ T cells were seeded with anti-CD3 (50 
ng/mL) in 6-well tissue culture-nontreated plates at a density of 1x106 cells/well (0,11 x106 
monocytes/cm2) and incubated at 37ºC, under a 5% CO2 humidified-atmosphere. At day 3 
and 7, cells were collected to assess cell purity by FACS, using specific anti-CD4-FITC 
(ImmunoTools) and anti-FoxP3-PE (BD Pharmingen) antibodies. The morphology, adhesion 
and confluence of Treg cells were examined in the third and seventh days using a Olympus 
CKX41 (SC30) optical microscope and photographed with the anaySYSgetIT, 5.1 Software. 
For 7 days cultures, cells were nourished on day 3 by changing 1/5 of the medium and 
keeping the same concentration of anti-CD3 mAb (OKT3). Tregs isolation was performed 
twice using whole buffy coats from two distinct healthy blood donors. 
 
Flow cytometry 
The purity of CD4+CD25+FoxP3+ T cells was determined by fluorescence-activated cell 
sorting (FACS), using the cell surface receptors CD4+ and CD25+ for Tregs. Isolated 
CD4+CD25+ T cells were further characterized for intracellular FoxP3 expression, a lineage-
defining transcription factor (Table 1). For this, cells were collected and centrifuged at 288xg 
during 5 minutes at 4C. The supernatant was discarded and the pellet was resuspended 
with FACS staining buffer (PBS supplemented with 2% FBS [Lonza] and 1% sodium azide 
[Sigma-Aldrich]). Cells were divided and plated in ice into FACS-staining-U-bottom plates at 
a density of 5x105-1x106 cells/condition. The plate was centrifuged at 242 xg during 3 
minutes at 4C, and the supernatant was removed by discarding it by a single fast 
movement. For cell surface receptors, cells were stained with anti-human CD4-FITC 
(ImmunoTools) and anti-human CD25-APC (BD Biosciences) diluted in FACS buffer (1:10 
ratio), for 30 minutes, on ice and in the dark. After this time, cells were washed in FACS 
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buffer and centrifuged. After staining for cell surface molecules, cells were fixed in 4% 
paraformaldehyde (PFA) (Sigma-Aldrich) for 10 minutes at RT. For intracellular staining of 
FOXP3 cells were permeabilized in 0,2% Triton X-100 (Sigma-Aldrich) for 5 minutes at RT 
and stained with anti-human anti-FoxP3-PE (BD Pharmingen) diluted in FACS staining 
buffer (1:1 ratio) for 30 minutes at RT. After this period, cells were centrifuged as previously, 
supernatants were discard, the pellet was washed, resuspended in PBS 1x, collected into a 
FACS tube, and stored until acquisition at 4ºC, protected from light. Isotype-matched 
antibodies, IgG2a-FITC, IgG1,k-APC and IgG1-PE were used as negative control, to define 
background staining (Table 1). 
Cells were acquired on BD AccuriTM C6 Flow cytometer BD CSampler (BD 
Biosciences), using BD AccuriTM C6 Software (collecting 10 000 cells). Analysis was 
performed with the same software. Percentage of positive cells was obtained by subtracting 
the respective isotype control. 
 
Table 1. Antibodies used for monocytes and CD4+CD25+T cell phenotyping by FACS 
 
Co-cultures of human CD14+ monocytes and CD4+CD25+ Tregs 
Isolated human CD14+ monocytes and CD4+CD25+ T cells mono-cultures and co-cultures 
(1:1 or 2:1 ratios, Mac:CD25+ T cell) were performed in 24-well tissue culture-treated plates 
(Falcon) with glass coverslips (Deckglasser) for 3 and 7 days in an autologous setting and 
in the presence of 50 ng/mL of soluble anti-CD3 monoclonal antibody. After this time, 
cultures were used for invasion assays with RKO or SW620 CRC cell lines, conditioned 
media (CM) stored for enzyme-linked immunosorbent assays (ELISA) and zymography 
analysis, cell viability assays and to assess morphology and macrophage molecular profile 
by immunocytochemistry (ICC). As controls, each cell population was cultured alone. The 
experimental design is illustrated in supplementary figure 1a. For 7 days cultures, cells were 
nourished on day 3 by changing 1/5 of the medium and keeping the same concentration of 
anti-CD3 mAb. 
 
 
Antigen Format Clone Isotype Stain Specificity Manufacturer Cat no. 
CD4 FITC MEM-241 IgG2a Surface Lymphocyte ImmunoTools 21278043 
CD25 APC 2A3 IgG1,k Surface Tregs BD Biosciences 340907 
FoxP3 PE 259D/C7 IgG1 Intracellular Tregs  BD Pharmingen 560046 
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Cell viability and metabolic assays 
The trypan blue-exclusion assay, based on cell membrane integrity, was used to estimate 
the number of viable immune cells present in mono or co-cultures, after 3 and 7 days. For 
this, culture supernatants were removed, diluted (1:1 ratio) in trypan blue dye (Sigma-
Aldrich) and cells were counted in a Neubauer chamber. Additionally, to assess the viability 
of adherent cells, coverslips were incubated in complete RPMI medium with trypan blue dye 
(1:1 ratio) for 3 minutes, washed in PBS, and visualized through an Olympus CKX41 (SC30) 
optical microscope. To estimate total adherent live and dead cells, 6 random areas within 
each coverslip were considered and divided by the total area of the coverslip (diameter 
12mm). Since trypan blue is a membrane impermeable molecule, the number of viable cells 
was estimated upon subtraction of the blue stained dead cells. Results are presented as the 
percentage of viable cells, present in suspension in the medium or adhered to the coverslip, 
over the total number of cells [(Total of live cells/Total of cells) x 100]. 
To complement this qualitative data, immune cells metabolic activity was determined 
though the resazurin reduction assay. Briefly, after 3 or 7 days of seeding, cells were 
incubated with resazurin redox dye (0.01 mg/mL) (Sigma-Aldrich) for 4 hours at 37°C and 
5% CO2, after which 200 μL/well were transferred to a 96-well black plate (MICROTESTTM, 
Falcon). Wells containing only complete RPMI medium with resazurin were used as blank. 
Two technical replicates were performed. Fluorescence intensity was measured (530 nm 
Ex/590 nm Em), using the multi-mode microplate reader Synergy MX (BioTek). Results are 
presented as relative fluorescence units (RFU) per 1x105 cells and represent the differences 
in fluorescence intensity (fluorescencesample–fluorescenceblank). 
 
Immunocytochemistry 
Coverslips with cells fixed in 4% PFA were washed in PBS and quenched with 50 mM NH4Cl 
for 10 minutes. After washing with PBS under agitation, cells were permeabilized with 0.2% 
Triton X-100 for 5 minutes. Cells were washed as previously, blocked for 45 minutes with 
5% bovine serum albumin (BSA) (Sigma-Aldrich) and incubated for 1h30 with the 
monoclonal mouse primary antibodies anti-human CD80 (DAKO, PG-M1) or anti-human 
CD163 (Cell Marque,163M-16) or anti-human α-tubulin (Fisher Scientific, MAC 387). After 
washing with PBS, coverslips were incubated for 1 hour with goat anti-mouse AlexaFluor-
594-conjugated secondary antibodies (Invitrogen, 927075) and washed. For actin staining 
coverslips were incubated with phalloidin-FITC for 15 minutes at RT. After the final wash, 
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coverslips were mounted on Vectashield with 6-diamidino-2-phenylindole (DAPI, Vector 
Laboratories, Burlingame, CA, USA). Cells were visualized with a Zeiss Axiovert 200M 
fluorescence microscope (Carl Zeiss, Aalen, Germany). 
 
Enzyme-linked immunosorbent assay (ELISA) 
Levels of IFN-, IL-6, IL-10 and total transforming growth factor (tTGF-β1) cytokines present 
in CM from cultures, prior and/or after invasion assays, were measured by ELISA, according 
to manufacturer’s instructions (BioLegendMAX, San Diego, CA, USA). For IFN- and IL-6, 
16 hours prior the ELISA, capture antibodies, diluted in coating buffer, were added to 96-
well plates, sealed and incubated overnight (ON) at 4ºC. Then, wells were incubated with 
assay diluent at RT for 1 hour, with agitation, to block non-specific binding. From here the 
procedure was similar for all ELISA Kits. Briefly, after washing, samples were incubated in 
96-well plates pre-coated with a capture antibody, specific for the cytokine in analysis, during 
2 hours at RT with agitation. After washing, a detection antibody solution was added and 
incubated for 1 hour at RT with agitation. Then, wells were washed, incubated with Avidin-
HRP D solution for 30 minutes at RT with agitation. Wells were washed again, incubated 
with substrate solution F or TMB substrate solution at RT, with agitation, until the colour 
develops according to the amount of cytokine bound. According to the cytokine, standard 
dilutions were prepared from 1000pg/mL to 7.8 pg/mL. The reaction was stopped with stop 
solution and the absorbance was read at 450 nm and 57 0nm on a SynergyMx fluorometer 
(Biotek) and using the Gen5by software. Finally, the values obtained at 570 nm were 
subtracted to the values obtained at 450 nm.  
 
Invasion Assays 
3D-coated matrigel invasion assays monitor cell movement through a barrier consisting of 
extracellular matrix components (collagen type IV, fibronectin, proteoglycans amongst 
other), which mimics the basement membrane that cancer cells have to cross to invade and 
metastasize. This in vitro assay has been successfully used to quantify the capability of cells 
to penetrate basement membranes in response to factors present in the medium57,142. 
Therefore, 8-µm-pore-size matrigel coated-inserts (BD Biosciences) were allowed to 
rehydrate in complete RPMI medium for 2 hours at 37ºC and 5% CO2. After this time, a 
suspension of 0.5x106 RKO or SW620 cells was incubated in the upper compartment of 
each insert in the absence (-) or in the presence of macrophages (Mac), CD4+CD25+ T cells 
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(CD25+T) or both (Mac:CD25+T to 1:1 and 2:1 ratio) in the lower compartment (Figure S1b). 
The immune cells were already seeded in the 24-well plate for 3 or 7 days. To guarantee 
the contact between the insert and the conditioned medium, the final volume of the lower 
compartments was brought to 750 µL by adding 250 µL of complete medium supplemented 
with anti-CD3 antibody (50 ng/mL). For control condition (-), 750 µL of complete medium 
supplemented with anti-CD3 (50 ng/mL) was placed in the lower compartment. After 24 
hours of indirect culture at 37ºC and 5% CO2, inserts were removed, washed in PBS, fixed 
in 4% PFA, mounted in Vectashield with DAPI and visualized through a Zeiss Axiovert 200M 
fluorescence microscope. To cover all the filter area, invasive cells were scored in 13 
microscopic fields with 20x objective when DAPI-counterstained nuclei passed through the 
filter pores. The invasion assays were performed with 5 different donors for RKO and 3 
donors for SW620 cell line. After matrigel invasion assays, CM were stored for ELISAs, 
zymography and coverslip were used to assess macrophage molecular profile by ICC. 
 
Zymography  
Conditioned media from macrophage, CD4+CD25+ Treg cells or co-cultures after invasion 
assays were analysed by gelatin zymography to evaluate MMP9 and 2 activity. Protein 
content was determined by Dc Protein kit (Bio-Rad, Amadora, Portugal) and 16 µg of protein 
were mixed with sample buffer (10% sodium dodecyl sulfate, 4% sucrose and 0.03% 
bromophenol blue in 0.5 M Tris–HCl, pH 6.8) to a final volume of 15 µL, loaded and 
separated on 10% polyacrylamide gels containing 0.1% gelatin (Sigma-Aldrich) as 
substrate, at 80 V and 120 mA. After electrophoresis, gels were washed twice with 2% triton 
X-100 and once with deionized water. Gelatin gels were subsequently incubated for 16 
hours at 37ºC in appropriate MMP2 and MMP9 substrate buffer [50 mM Tris–HCl, pH 7.5 
and 10 mM CaCl2]. After this time, gels were washed in deionized water and stained with 
0.1% Coomassie Brilliant Blue R-250 (Sigma-Aldrich) for 30 minutes. MMPs molecular 
weight and activity were estimated by densitometric analysis (QuantityOne, Bio-Rad). 
 
Western blot 
RKO cells, at approximately 80% confluency, were serum-starved ON and treated with CM 
from macrophages (CM(mac)), CD4+CD25+ T cells (CM(CD25+T)) or co-cultures at 1:1 
(CM(1:1)) and  2:1 ratios (CM(2:1)), or with complete RPMI as control (CM(RPMI)) for 1 
hour. Then, monolayers were washed in PBS and cell lysates prepared in cold lysis RIPA 
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buffer [50 mM Tris-HCl-pH 7.5, 1% NonidetP-40, 150 mM NaCl], supplemented with 
proteases and phosphatases (2 mM ethylenediaminetetraacetate [EDTA], 3 mM sodium 
orthovanadate [Na3VO4], 20 mM sodium fluoride [NaF], 1 mM phenylmethylsulfonyl fluoride 
[PMF], 10 µg/mL aprotinin and leupeptin) for 15 minutes. Then, cells were scraped, collected 
and centrifuged for 10 minutes at 4ºC at 392 xg. Protein concentration was determined as 
previously described and 35 µg of protein mixed with sample buffer (Laemmeli 4x, β-
mercaptoethanol [Biorad], bromophenol blue 0.25%) were loaded on 10% sodium dodecyl 
sulfate (SDS)-polyacrylamide gel. After electrophoresis, bands were transferred onto 
hybond nitrocellulose membranes (Amersham) in a blot cassette submerged in transfer 
buffer supplemented with methanol and SDS 10%, ON at 100 V 120 mA. Membranes were 
incubated with Ponceau Red Solution (Sigma-Aldrich) to allow the visualization of 
transferred bands and washed twice in deionized water. After blocking with 4% BSA in 
PBS+0.5% Tween-20 (Sigma-Aldrich) for 30 minutes, membranes were incubated for 1 hour 
with rabbit polyclonal antibodies against phospho-EGFR(Y1086) (ThermoFisher, 36-9700), 
Akt (Cell Signaling, 9272S), phospho-Src(Y416) (Cell Signaling, 2102S), Src (Cell Signaling, 
2108S) or α-tubulin (Sigma-Aldrich, T5168) or with mouse monoclonal antibodies against 
EGFR (BD Transduction, 610016) or phospho-Akt (S473) (Cell Signaling, 9246S). Donkey 
anti-rabbit or sheep anti-mouse-HRP-conjugated secondary antibodies (GE Healthcare) 
were used followed by ECL-Detection (GE Healthcare). Bands of phosphorylated proteins 
were quantified by densitometric analysis (QuantityOne-BioRad) and compared with the 
levels of the respective total proteins and of α-tubulin, as loading controls. 
 
Immunohistochemistry 
34 tissues samples from Hospital São João Tissue and Tumour Bank (gently provided by 
Professor Fátima Carneiro) were immunohistochemically stained for FoxP3 expression. 
Similarly to most published studies addressing the prognostic value of Tregs in cancer we 
used clone 236A/E7 (Abcam, ab20034), that was showed to detect mostly CD4+CD25+ T 
cells88. 3 μm-thick tissue sections were prepared from formalin-fixed, paraffin-embedded 
specimens. After deparaffinization, in clear-rite, and rehydration, using graded alcohol 
washes, slides were boiled at 98ºC in 10 mM citrate buffer (pH 6) for 10 minutes, for antigen 
retrieval. Subsequently, slides were allowed to cool down for 20 minutes and washed in 
0.02% PBS(1x)-Tween (PBS-t0.02%). Endogenous peroxidase activity was blocked by 
incubation with 3% H2O2 solution in methanol for 10 minutes at RT in the dark, followed by 
new washing step with PBS-t0.02%. Tissue sections were limited with a hydrophobic pen and 
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Ultra V Block (Thermo) was applied for 30 minutes in a humidified chamber to block 
unspecific antigens. For immunostaining, slides were incubated with the mouse monoclonal 
anti-human FOXP3 antibody diluted with Large Volume Ultra AB Dilutent (Dako) to 1:100, 
for 1h30 at RT. After incubation with primary antibody, slides were washed with PBS-t0.02% 
and incubated with labelled polymer horseradish peroxidase rabbit/mouse secondary 
antibody for 30 minutes (Envision Plus Detection System; Dako). Following a new washing 
step, antigen detection was performed by incubation with 3,3-Diaminobenzidine (DAB+ 
chromogen, DakoCytomation, Glostrup, Denmark) for 6 minutes, and washed 10 minutes in 
running water. Then, sections were counterstained with hematoxylin (AppliChem, Germany) 
for 1 minute, washed in running water for 15 minutes, rehydrated through graded alcohol 
incubations followed by 10 minutes in clear-rite and mounted with Entellan (Thermo 
Scientific). Tissue section from lymph nodes and tonsil were used as positive control.  
 
Measurement of FoxP3 density 
Foxp3-positive cells were quantified in three distinct regions: the normal colonic mucosa 
(NCM), tumour nest (TN) and tumour invasive front (IF). The NCM was defined as the region 
most far away from the outline of the tumour. The tumour nest was defined as the area apart 
from the tumour outline toward the center of the tumour. The invasive front was defined as 
the most advanced front of the tumour in the interface of the tumour and normal adjacent 
mucosa or, in an advanced stage, the submucosa. FoxP3-positive cells were manually 
counted in 10 high-power field of each region and the average number of cells in each region 
was considered for 30 tissue samples. In the remaining 4 tissue samples, the three areas 
could not be distinguished, therefore, were not considered. 
 
Statistical Analysis 
Data were analysed with Mann–Whitney test for comparisons between two groups or with 
Kruskal-Wallis test followed by a correction with Dunn’s multiple comparison test when more 
than 3 conditions were compared at the same time. All statistical analysis were performed 
using GraphPad Prism v6, GraphPad Software, (San Diego, CA, USA -trial version), and 
expressed as mean values of at least three independent experiments ± standard deviation 
(SD). Differences in data values were considered significant at a P-value of <0.05. 
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Results 
Macrophages display higher levels of adhesion and differentiation 
in 24-well plates with glass coverslips 
Human monocyte isolation from peripheral blood and buffy coats was already established 
in our laboratory57. Previous experiments using FACS analysis revealed that on average 80-
85% of the RosetteSep isolated monocytes expressed CD14, a monocyte/macrophage 
lineage marker. To optimize in vitro culture conditions, isolated human CD14+ monocytes 
were seeded, in the absence of exogenous stimuli, on three different substrates: 6-well 
tissue culture-treated and -non-treated plates, at a density of 0,13x106 monocytes/cm2, or 
on 24-well tissue culture-treated plates containing glass coverslips/well, at a density of 
0,26x106 monocytes/cm2. In vitro cultures were maintained for 3 and 7 days to allow purified 
monocyte differentiation into macrophages, and their density, adhesion and morphology 
were analysed. At day 3, monocytes exhibited low levels of differentiation and adhesion to 
the three substrates, while adherent monocyte-derived macrophages displayed very small 
round morphology (Figure 5, left panels). At day 7, macrophage density, adhesion and 
morphology between substrates differed (Figure 5, right panels). On 6-well tissue culture-
treated plates, loss of cellular density and low levels of differentiation were observed, with 
macrophages displaying a small and round morphology (Figure 5, upper panel). In contrast, 
on 6-well tissue culture-non-treated plates (Figure 5, middle panel) and 24-well tissue 
culture-treated plates with glass coverslips inserted (Figure 5, lower panel) a higher cellular 
density was observed. Additionally, adherent/differentiated macrophages displayed a 
heterogeneous morphology and the most elongated exhibited long protrusions (Figure 5, 
lower panel, and arrowheads), suggesting higher levels of differentiation on this substrate. 
Looking into more detail for monocytes cultured on 24-well tissue culture-treated plates with 
glass coverslips, the number of adherent macrophages seemed to be higher in comparison 
to other substrates. For this reason, all subsequent experiments with monocytes were 
performed using 24-well tissue culture-treated plates with glass coverslips. 
 
Isolation of CD4+CD25+ T cells with StemCell isolation kit allows an 
autologous setting between CD14+ monocytes and CD4+CD25+ T 
cells 
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Human CD4+CD25+ Tregs cells were isolated through a negative selection (CD4+ T cells) 
followed by a positive selection (CD25+ T cells) procedure. To optimize cell isolation, two 
commercially available regulatory T cell isolation kits were tested: the Human Regulatory T 
Lymphocyte Separation Set from BD Biosciences (BD) and the Regulatory T cell Isolation 
Kit from StemCell Technologies (SC). Since our main goal was to perform monocyte-Treg 
co-cultures, an autologous setting was designed and a sample from the same blood donor 
Figure 5. Macrophage display higher levels of adhesion and differentiation on 24-well plates with glass coverslips. 
Monocyte isolation was performed by negative selection using RosetteSep monocyte enrichment kit. Monocytes were seeded 
on three different substrates: 6-well tissue culture-treated plates (upper panels), 6-well tissue culture-non-treated plates 
(middle panels) and 24-well tissue culture-treated plates with glass coverslips inserted (lower panels), for 3 (left panels) or 7 
days (right panels), to allow monocyte to macrophage differentiation. After this time, macrophage morphology and adhesion 
were examined. Cells were visualized and photographed at 200x magnification with an Olympus CKX41 (SC30) microscope. 
Arrowheads indicate macrophage long protrusions. Scale bar represents 50 µm. Experiments were performed with 2 donors. 
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was used to isolate both immune cell populations. Therefore, to combine monocyte isolation 
with BD regulatory T cell isolation Kit, buffy coats were initially divided, whereas to combine 
monocyte isolation with SC regulatory T cell isolation Kit, PBMCs were first collected from 
buffy coats and then divided for immune cell isolation. These differences resulted from 
specifications of the isolation protocols, as provided by the manufacturers. Our results 
Figure 6. Isolation of Tregs with StemCell isolation kit allows an autologous setting between CD14+ monocytes and 
CD4+CD25+ T cells. For an autologous setting the same blood donor was used to isolate CD14+ monocytes and CD4+CD25+ 
Tregs. a) Monocyte (Mon SC) isolation was combined with BD regulatory T cell isolation (Tregs BD) or with StemCell regulatory 
T cell isolation Kit (Tregs SC). Buffy coats or PBMCs were first divided to isolate both immune cells. Non-divided PBMCs were 
also used to isolate only monocytes or only Tregs with SC Kit. Results are presented as the number of isolated cells x106. 
The purity of CD4+CD25+ T cells isolated with SC Kit was assessed by FACS. b) Cell aspect-ratio (left panel) and 
CD4+CD25+FoxP3+
 
(middle and right panels) triple-staining immediately after purification. c) Respective IgGs were used to 
subtract background staining. Data are presented as box and whisker plots: white and grey boxes extend from the 25th to the 
75th percentile, with a black line at the median; whiskers extend to show the highest and lowest values. For isolations with 3 
distinct donors only the median value and range are shown. Experiments were performed at least with 3 distinct donors. *, 
significantly different at P<0.05. 
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showed that when the buffy coat was initially divided to isolate these immune populations 
the yield of Tregs was sufficient (7.53x106±2.19 CD4+CD25+ T cells) but the yield of 
monocytes was very low (0.50x106±0.50 CD14+ monocytes), compromising their isolation 
and seeding (Figure 6a). When the whole buffy coats’ blood was centrifuged to obtain 
PBMCs and further divided to isolate CD14+ monocytes and CD4+CD25+ T cells with the SC 
isolation kit, the yield of CD4+CD25+ T cells was lower (3.32x106±1.26 CD4+CD25+ T cells) 
but the monocyte isolation was successful (23.62x106±11.68 CD14+ monocytes). When 
comparing isolation from half or whole PBMCs, the yield of monocytes was similar (Non-
parametric Mann-Whitney Test; P=0.83), although the yield of CD4+CD25+ T cells was 
significantly different (Non-parametric Mann-Whitney Test; P<0.05) (Figure 6a). Altogether, 
our results evidence that SC isolation of CD4+CD25+ T cells represents the best compromise 
to purify both CD14+ monocytes and CD4+CD25+ T cells, and to further perform an 
autologous setting between these immune populations. For this reason, all subsequent Treg 
isolations were performed using the SC kit. 
To assess the purity of the SC isolated CD4+CD25+ T cells, FACS was performed 
immediately after isolation (Figure 6b and c). The population of interest was selected and gated 
based on cell aspect ratio (Forward scatter (FSC-A), for size, and side scatter (SSC-A), for 
cell complexity). Along our experiments, the yield of isolated T cells was, on average, 77% for 
CD4+CD25+ T and 94% for FoxP3. These results indicate that the majority of the isolated 
cells expressed Treg characteristic markers, although the presence of a residual fraction of 
CD4+CD25mid/low T cells could not be ruled out. For this reason we decided to designate this 
population as CD4+CD25+ T cells. 
 
Isolated T cells modify their morphology and FoxP3 expression 
profile after 3 and 7 days of culture 
For a better analysis of CD4+CD25+ T morphology, cells were isolated using the SC kit and 
seeded on 6-well tissue culture-non-treated plates, at a density of 1x106 cells/well. To 
guarantee Treg cell activation and function143, soluble anti-CD3 monoclonal antibody was 
added to all cultures. In vitro cultures were maintained for 3 and 7 days and CD4+CD25+ T 
cells density, adhesion and morphology were subsequently analysed. Generally, 
CD4+CD25+ T cells displayed a small round morphology and very low levels of adhesion 
(Figure 7a). At day 3, and especially at day 7 after seeding, CD4+CD25+ T cells became a 
heterogeneous population, with some elongated cells, while the majority remained rounded 
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but smaller. Through smooth plate agitation, we observed that cells were more adhered at 
day 7 than at day 3. Additionally, through microscopic observation, cellular confluency 
remained similar at all time points. However additional quantitative testes are required to 
confirm this observation. 
 
To assess cell purity, CD4+CD25+ T cells phenotype was evaluated by FACS for 
CD4 cell surface expression immediately after isolation and for CD4 and FoxP3 intracellular 
marker expression, at days 3 and 7 after isolation (Figure 7b, c and d). The population of 
interest was selected and gated (Figure 7b) based on cell aspect ratio. In concert with the 
previous morphological analyses, immediately after isolation, T cells displayed a well-
defined aspect ratio, restricted in size and complexity. However at day 3 and especially at 
Figure 7. Isolated T cells modify their aspect ratio and FoxP3 expression profile after 3 and 7 days of culture. 
CD4+CD25+ T isolation was performed by negative selection followed by a positive selection using the SC kit. Cells were 
seeded in the presence of anti-CD3 mAb on 6-well tissue culture-non-treated plates at the density of 1x106 cells. a) 
Morphologic evaluation of CD4+CD25+ T at day 0, 3 and 7 after isolation. Cells were visualized at 200x magnification. b) 
Aspect ratio and c) population purity by CD4 (activated T cell marker), immediately after purification (day 0, left panels), and 
CD4 and FoxP3 (Treg lineage marker) double staining at days 3 and 7 (middle and right panels) after seeding. Respective 
IgGs were used to subtract background staining. Experiments were performed with only one blood donor. Arrowheads indicate 
elongated cells. Scale bar represents 50 µm. 
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day 7, the aspect ratio of the seeded population reduced in size (FSC-A) and increased in 
complexity (SSC-A). Regarding purity, isolation resulted in an average of 89% CD4+ T cells 
(Figure 7c, left panel). At day 3, 77.5% of the population was CD4+FoxP3+ (Figure 7c, middle 
panel) while at day 7 two populations could be distinguished: one CD4+FoxP3- (14.3%), and 
another CD4+FoxP3+ (40.5%) (Figure 7c, right panel). These results demonstrate loss of 
FoxP3 expression upon long-time culture.  
 
Macrophages and CD4+CD25+ T cell-educated macrophages are 
viable and metabolically active while CD4+CD25+ T cells are viable 
but less active  
The impact of Tregs on macrophage morphology and viability was assessed in in vitro cell 
cultures. Isolated human CD14+ monocytes and CD4+CD25+ T cells mono- and co-cultures 
(1:1 or 2:1 ratios, Mac:CD25+T) were performed using 24-well tissue culture-treated plates 
with glass coverslips, for 3 and 7 days, in an autologous setting. To ensure T cell activation, 
an anti-CD3 mAb was added to all conditions. Co-stimulation of CD28 was provided by the 
presence of monocytes in the culture plate. To assess cell morphology by actin/tubulin 
cytoskeleton organization, F-actin and α-tubulin staining was performed. Lower levels of 
adhesion and differentiation were observed at day 3 than at day 7 after seeding, especially 
in CD4+CD25+ T cells mono-cultures. At day 3, macrophages displayed preferentially a 
round morphology whereas when co-cultured with CD4+CD25+ T cells a higher number of 
elongated macrophages were observed, particularly at the 1:1 ratio (Figure 8a, upper panel). 
This was further confirmed at day 7, where macrophages at 1:1 ratio were more elongated 
than at 2:1 ratio and macrophage mono-cultures (Figure 8a, lower panel). In CD4+CD25+ T 
cells mono-cultures, at day 3, cells displayed a round morphology, while at day 7 the 
population became heterogeneous, presenting both elongated and small rounded cells, 
which is in concert with previous analyses. To rule out that co-cultures did not affect the 
sustainability of each immune population, cell viability was assessed by trypan blue-
exclusion assay (Figure 8b) and cell metabolic activity by resazurin reduction assay (Figure 
8c). No differences in terms of cell viability were observed between the distinct conditions 
(>80%) (Figure 8b). Regarding metabolic activity, macrophages (0.28±0.08x104 RFUs per 
1x106 cells) and macrophage-CD4+CD25+ T co-cultures (1:1 ratio: 0.31±0.08x104 RFUs per 
1x106 cells; 2:1 ratio: 0.36±0.12x104 RFUs per 1x106 cells) presented slightly lower levels 
of activity at day 3 than at day 7 after seeding (macrophages: 0.36±0.14x104 RFUs per 1x106 
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cells; 1:1 ratio: 0.41±0.08x104 RFUs per 1x106 cells; 2:1 ratio: 0.56±0.09x104 RFUs per 
1x106 cells). In contrast, CD4+CD25+T mono-cultures seemed to have low levels of activity 
at both days, but especially at day 7 (0.07±0.04x104 RFUs per 1x106 cells, at day 3; 
0.02±0.01x104 RFUs per 1x106 cells, at day 7). Interestingly, after 7 days, only CD4+CD25+ 
T cell-educated macrophages ratio 2:1 exhibited significantly higher metabolic activity than 
CD4+CD25+ T cell mono-cultures (Non-parametric Kruskal-Wallis Test; P<0.05), as 
20 μm 
Figure 8. Macrophage and CD4+CD25+ T-educated macrophages are viable and metabolically active while CD4+CD25+
T cells are viable but less active. Monocytes and CD4+CD25+ Treg cells  were isolated from buffy coats and seeded as single 
or co-cultures (1:1 and 2:1, Mon:CD4+CD25+ T ratio) with an anti-CD3 mAb, on 24-well tissue culture-treated plates with glass 
coverslips. Cells were fixed in 4% PFA and a) stained for actin and tubulin at day 3 (upper panels) and 7 (lower panels) after 
seeding. F-actin was stained with phalloidin-FITC (green), α–tubulin with a specific monoclonal antibody followed by incubation 
with AlexaFluor594 secondary antibody (red) and nuclei were counterstained with DAPI (blue). b) For trypan blue exclusion 
assay cells in the medium and in the coverslips were incubated with trypan blue and then counted in a Neubauer chamber. 
Cells exhibiting blue-stained nuclei were considered dead and results are expressed as percentage of viability (%), calculated 
through (Totallive cells/Totalcells)x100 for day 3 (open bars) and day 7 (grey bars). c) Metabolic activity was assessed by resazurin 
reduction over 4h. Results are expressed in relative fluorescence units (RFU) per 1x105 cells for day 3 (open bars) and day 7 
(grey bars). Bars represent mean values of independent experiments, performed with three distinct donors, and flags indicates 
SD. *, significantly different at P<0.05. Scale bar represents 20 µm. 
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demonstrated by their higher ability to reduce resazurin to resorufin (Figure 8c). These 
results suggest that macrophages and CD4+CD25+ T cell-educated macrophages were 
viable and active after 3 and 7 days of culture while CD4+CD25+ T cells were viable but 
metabolically less active.  
 
Co-cultures with isolated CD4+CD25+ T cells express CD163, but 
not CD80 
One of our goals was to determine the effect of CD4+CD25+ T cells on macrophage 
inflammatory profile. Therefore, monocyte-derived macrophages were cultured, for 3 and 7 
days, in the presence of Tregs and further characterized regarding CD80 (pro-inflammatory 
marker) and CD163 (anti-inflammatory marker) cell surface receptor expression (Figure 9a 
and b, respectively) and for IL-6, TGF-β and IFN- cytokines secretion profile (Figure 9 c 
and d, respectively). At day 3, mono- and co-cultures displayed lower levels of differentiation 
and consequently, the expression of macrophage cell surface markers was lower than at 
day 7. As expected from a naïve macrophage population, monocyte-derived macrophages, 
cultured alone and in the absence of exogenous stimuli, are a heterogeneous population 
expressing both CD80 and CD163 markers. Accordingly, macrophages alone secreted low 
levels of the distinct cytokines. Our results evidenced that since day 3 the presence of 
CD4+CD25+ T cells abrogated macrophage CD80 expression and reduced CD163 
expression, especially in 1:1 ratio co-cultures. However, conditioned media (CM) from co-
cultures of macrophages with CD4+CD25+ T cells (CM(1:1) and CM(2:1)) revealed slightly 
higher levels of IL-6 than from macrophages (CM(Mac)) alone (Figure 9c). The levels of 
tTGF-β remained similar in all conditions (Figure 9d). None of the cultures secreted 
detectable levels of IFN- after 3 or 7 days of seeding (data not shown). Overall, these results 
suggested that CD4+CD25+ T cells are inhibiting the expression of a pro-inflammatory 
receptor without fully inducing an anti-inflammatory profile. Of note, only one experiment 
was performed to evaluate the levels of cytokines available in the condition medium (CM) of 
the distinct conditions. Therefore, these results can be misleading regarding the general 
pattern of cytokine secretion of macrophage, CD4+CD25+ T cells and macrophage-
CD4+CD25+ T cell co-cultures.  
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a) CD80 cell surface marker 
b) CD163 cell surface marker 
Figure 9. Co-cultures with isolated CD4+CD25+ T cells express CD163, but not CD80. The phenotype of monocyte-
derived macrophages cultured alone or in the presence of CD4+CD25+ T cells (1:1 or 2:1, Mac:CD25+ T ratio) was 
characterized by cell surface receptor expression of a) CD80 and b) CD163 for 3 (upper panel) and 7 days (lower panels) 
after culture, and by secretion of c) IL-6 and d) tTGF-β cytokines measured by ELISA in conditioned media collected at day 
3 (white bars) and 7 (grey bars) after seeding. Negative control was used to subtract background staining. ICC analyses are 
representative of 3 experiments and ELISA resulted from conditioned media of a single experiment. CD80 and CD163 were 
stained with specific monoclonal antibodies followed by incubation with AlexaFluor594 secondary antibody (red) and nuclei 
were counterstained with DAPI (blue). Scale bar represents 20 µm. 
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Macrophages and CD4+CD25+ T cell-educated macrophages 
significantly induce RKO but not SW620 cancer cell invasion 
We have previously demonstrated that soluble factors produced by macrophages promote 
gastric and CRC cell invasion57. To clarify the role of CD4+CD25+ T cells on macrophage 
pro-invasive activity, macrophages or CD4+CD25+ Treg-educated macrophages were 
cultured for 3 or 7 days and further confronted with CRC cells, using 3D-matrigel invasion 
assays. In these experiments, two different cell lines were used: RKO, isolated from a 
primary colon adenocarcinoma, and SW620, isolated from a colorectal cancer lymph node 
metastasis. For control purposes, each cell population was cultured alone during the same 
time points. RKO displayed higher ability to invade the matrigel (106.3±40.73 invasive cells) 
than SW620 (12.30±7.96 invasive cells) (Figure 10a and b, respectively). Our results 
evidenced that RKO cancer cell invasion was significantly promoted by macrophages (Non-
parametric Kruskal-Wallis Test; P<0.05) and by CD4+CD25+ T cell-educated macrophages 
at 2:2 (Non-parametric Kruskal-Wallis Test; P<0.05) and especially at 2:1 ratios (Non-
parametric Kruskal-Wallis Test; P<0.01), upon 7 days of differentiation. Interestingly, SW620 
cancer cell invasion was not significantly promoted by macrophages or by macrophages and 
CD4+CD25+ T cell co-cultures. Since significant differences were only found with RKO 
invasion, the remaining indirect co-cultures were only established with this cancer cell line 
and not with SW620 CRC cells. 
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Figure 10. Macrophages and CD4+CD25+ T-educated macrophages significantly induce RKO but not SW620 cancer 
cell invasion. RKO or SW620 human colon cancer cells CD4+CD25+ T cells were incubated for 24 h at the upper compartment 
of matrigel-coated invasion chambers, in the presence of: RPMI medium (-), macrophages (Mac), CD4+CD25+ T cells 
(CD25+T), Mac and CD4+CD25+ T cells co–cultured at 1:1 or 2:1 (Mac:CD25+T) ratio, during 3 (white bars) or 7 (grey bars) 
days. Bars represent mean values of independent experiments ± SD. RKO invasion assay was performed with an n=5 and 
SW620 was performed with an n=3. *, significantly different at P<0.05, ** significantly different at P<0.01.  
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CD4+CD25+ T cell-educated macrophages in indirect contact with 
RKO cells express CD163, but not CD80, and display a “mixed” 
cytokine secretion profile  
We have previously described that IL-10-stimulated macrophages (anti-inflammatory-like 
profile) displayed higher pro-invasive activity than LPS-stimulated macrophages (pro-
inflammatory-like profile)58. Here, we aimed to understand if the observed pro-invasive 
activity induced by CD4+CD25+ T cell-educated macrophages was associated with the 
acquisition of an anti-inflammatory profile upon indirect co-culture with RKO cancer cells. 
Therefore, macrophage and CD4+CD25+ T cell-educated macrophages cell surface receptor 
(CD80 and CD163) expression and cytokine (IL-6, IFN-, tTGF-β and IL-10) secretion 
profiles were assessed, upon 24h of indirect co-cultures. 
In the presence of RKO, at day 3 + 24h, macrophages in mono-cultures expressed 
low levels of CD80 (Figure 11a) and intermediated levels of CD163 (Figure 11b). However, 
at day 7 + 24h, the expression of these markers was upregulated in almost all macrophages 
(Figure 11a and b), resembling a heterogeneous population. At day 3 + 24h with RKO, 
CD4+CD25+ T cell-educated macrophages expressed low levels of CD80, whereas at day 7 
+ 24h the expression of this pro-inflammatory marker was completely suppressed (Figure 
11a). Regarding CD163, at day 3 + 24h with RKO, the expression of this marker on 
CD4+CD25+ T cell-educated macrophages was negative at 1:1 and low at 2:1 ratios (Figure 
11b). However, at day 7 + 24h, the levels of CD163 on CD4+CD25+ T cell-educated 
macrophages were heterogeneous at 1:1 and at 2:1 ratios (Figure 11b), suggesting an up-
regulation of this anti-inflammatory marker in long-term co-cultures. 
Regarding the cytokine secretion profile (Figure 12), our results showed that when 
CD4+CD25+ T cell-educated macrophages were co-cultured in the presence of RKO cells 
(CM(1:1+RKO) and CM(2:1+RKO)) the levels of secreted IL-6, IFN- and IL-10 were higher 
than those of each immune population cultured with RKO cells (CM(Mac+RKO) and 
CM(CD4+CD25+ T+RKO)), at both 3 + 24h and 7 + 24h days. Interestingly, none of these 
cytokines was detected in CM(RKO) and CM(Treg+RKO), but low levels of IL-6 and IL-10 
were detected in CM(Mac+RKO). These results suggest that the high levels of the cytokines 
present in macrophage-CD4+CD25+ Treg population derived from the immune cell 
populations, rather than from RKO cancer cells. Interestingly, the levels of tTGF-β were 
similar in all conditions (Figure 12). At day 3 + 24h with RKO, 1:1 co-cultures (CM 
(1:1+RKO)) secreted significantly more IL-6, IL-10 and IFN- to the culture medium than 
FCUP 
Elucidating the role of macrophage and CD4+CD25+ regulatory T cells on colorectal cancer cell invasion
53 
 
CD4+CD25+ T cells (CM(CD4+CD25+ T+RKO)) (Non-parametric Kruskal-Wallis Test; 
P<0.05) and more IFN- than macrophages (CM(Mac+RKO)) (Non-parametric Kruskal-
Wallis Test; P<0.05). In 2:1 ratio (CM(2:1+RKO)), IL-10 secretion was significantly higher 
than in CM(CD4+CD25+ T+RKO) (Non-parametric Kruskal-Wallis Test; P<0.05), whereas 
IFN- was only higher than CM(Mac+RKO) at day 7+24h (Non-parametric Kruskal-Wallis 
Test; P<0.05). 
Our results suggest that the more pro-invasive activity of CD4+CD25+ T cell-educated 
macrophages occurs in parallel with the loss of a pro-inflammatory marker (CD80) without 
the acquisition of a classical anti-inflammatory profile (mixed expression of pro- and anti-
inflammatory cytokines is observed). 
Day 3  
+ 24h with RKO 
Day 7 
+ 24h with RKO 
Mac 1:1 2:1 
Negative control 
Day 3  
+ 24h with RKO 
2:1 1:1 Mac 
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a) CD80 cell surface marker 
b) CD163 cell surface marker 
Figure 11. CD4+CD25+ T-educated macrophages in indirect contact with RKO cells express CD163, but not CD80. 
Upon indirect co-cultures with RKO cancer cells, the profile of macrophages cultured alone or in the presence of CD4+CD25+ 
T cells (1:1 or 2:1, Mac: CD4+CD25+ T cell ratio) was characterized by cell surface receptor expression of: a) CD80 and b) 
CD163, for 3 days + 24h with RKO (upper panel) and 7 days + 24h with RKO (lower panels). Negative control was used to 
subtract background staining. Experiments were performed with three distinct donors. CD80 and CD163 were stained with 
specific monoclonal antibodies followed by incubation with AlexaFluor594 secondary antibody (red) and nuclei were 
counterstained with DAPI (blue). Scale bar represents 20 µm. 
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Pro-MMP9 activity is higher in CM of macrophage and macrophage 
co-cultures 
The activity of MMPs has been previously implicated in macrophage-pro-invasive activity57. 
Furthermore, the higher ability of IL-10-stimulated macrophages, rather than its LPS-
stimulated counterparts, to stimulate invasion was correlated to their higher ability to induce 
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Figure 12. CD4+CD25+T-educated macrophages in indirect contact with RKO cells display a “mixed” cytokine 
secretion profile. Upon indirect co-cultures with RKO cancer cells, the profile of macrophages cultured alone or in the 
presence of CD4+CD25+ T (1:1 or 2:1, Mac:CD25+T ratio) was characterized by secretion of: a) IL-6, b) IFN-, c) tTGF-β and 
d) IL-10 cytokines measured through ELISA, in conditioned media collected at day 3 + 24h with RKO (white bars) and 7 + 
24h with RKO (grey bars). Bars represent mean values of 3 independent experiments ± SD. *, significantly different at P<0.05. 
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MMP2 and MMP9 proteolytic activities58. To investigate the possible mechanisms underlying 
Figure 13. Pro-MMP9 activity is higher in CM of macrophage and macrophage co-cultures. Macrophage, CD4+CD25+ 
T cells and macrophage- CD4+CD25+ T cell co-cultures (1:1 and 2:1) were maintained for 3 or 7 days. Then, matrigel invasion 
assays were performed for 24h with RKO as an indirect co-cultures and a) CM from matrigel invasion assays containing 
RPMI and RKO (CM(RKO)), macrophages and RKO (CM(Mac+RKO)), CD4+CD25+ T cells and RKO (CM(CD25+T+RKO)), 
Macrophage-Treg cultured at 1:1 with RKO (CM(1:1+RKO)) or at 2:1 ratio with RKO (CM(2:1+RKO)) were analysed on gelatin 
zymograms. b) Proteolytic bands were revealed in white on a Coomassie Blue-stained background. Densitometry analysis 
using the QuantityOne software (BioRad) allowed quantification of b) pro-MMP9, c) MMP9 d) pro-MMP2 and e) MMP2 gelatin 
proteolytic activity. Results are expressed as percentage (%) of proteolytic activity in comparison with the activity present in 
RPMI culture medium and RKO (CM(RPMI+RKO)) at day 3 + 24h with RKO (white bars) or at day 7 + 24h with RKO (grey 
bars). Bars represent mean values of independent experiments ± SD (n=3). *, significantly different at P<0.05. 
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CD4+CD25+ T cells modulation of macrophage-mediated RKO cancer cell invasion, the 
proteolytic profile of gelatinases (MMP2 and MMP9) on CM derived from invasion assays 
was assessed by gelatin zymography (Figure 13a). Our results showed that, at day 7 + 24h, 
the CM from macrophage (CM(Mac+RKO)) and macrophage-CD4+CD25+ Treg co-cultures 
with RKO cells (CM(1:1+RKO) and CM(2:1+RKO)) presented higher pro-MMP9 proteolytic 
activity than the CM from negative control (CM(RPMI+RKO)) or from CD4+CD25+ T cells 
cultured alone with CRC cells (CM(CD25+T+RKO)) (Non-parametric Kruskal-Wallis Test; 
P<0.05) (Figure 13b). Although less evident, the proteolytic activity of gelatinases MMP9 
and MMP2 were also higher on CD4+CD25+ T-macrophage co-cultures than when these 
immune populations were cultured apart with the colorectal cancer cells. However, the levels 
of pro-MMP2 were very similar between all the conditions at both days (Figure 13c, e and 
d, respectively). These results suggest that pro-MMP9 is associated with the enhanced pro-
invasive activity of RKO in the presence of macrophages and of CD4+CD25+ T cell-educated 
macrophages. However, this does not explain the slightly higher pro-invasive ability of 
CD4+CD25+ T cell-educated macrophages in 2:1 ratio. This suggests that the differences 
found in the invasion profile of RKO did not exclusively rely on the proteolytic activity of these 
MMPs.  
 
Conditioned media from macrophages and from CD4+CD25+ T cell-
educated macrophages induce phosphorylation of EGFR in RKO 
cancer cells 
EGFR and its related signalling molecules have been implicated in macrophage-mediated 
cancer cell invasion57,58. Therefore, to further explore the possible mechanisms involved in 
the pro-invasive activities of macrophages and CD4+CD25+ T cell-educated macrophages 
on RKO cell invasion, EGFR-signalling pathway was tested by western blot (Figure 14). Our 
hypothesis was that similarly to macrophages, CD4+CD25+ T cell-educated macrophages 
would stimulate cancer cell invasion through the activation of EGFR and of its associated 
downstream partners. For further investigation, RKO cells were incubated for 1 h with RPMI, 
as negative control (-), with CM from macrophage (CM(Mac)) or with CM from 3 and 7 days 
of CD4+CD25+ T-macrophage co-cultures (CM(1:1) and CM(2:1)). Our results indicate that, 
after 1 hour of treatment, CM from macrophages and CM from CD4+CD25+ T cell-educated 
macrophages similarly enhanced the phosphorylation levels of cancer cell EGFR (Y1086) in 
comparison with the negative control (Figure 14). The differences obtained in the 
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phosphorylation levels of cancer cell cSrc (Y416) and AKT (T202/Y204) were not fully 
concordant between distinct donors and between conditions. However, at day 7, at 1:1 ratio 
cSrc-phosphorylation seems to be decreased in comparison with macrophages and Treg-
educated macrophages at 2:1 ratio. Altogether, these results suggest that similarly to 
macrophages, CD4+CD25+ T cell-educated macrophages may stimulate colorectal cancer 
Figure 14. Conditioned media from macrophages and CD4+CD25+ T cell-educated macrophages induce 
phosphorylation of EGFR in RKO cancer cells. RKO cells were treated, during 1h, with RPMI (-), CM from macrophages 
(Mac) and from macrophage-CD4+CD25+ T cell co-cultures (1:1 or 2:1 ratios) from 3 and 7 days. Cell lysates were analysed 
by western blot for phosphorylated EGFR (Y1086) (P-EGFR), cSrc (Y416) (P-cSrc), AKT (S473) (P-AKT). α–tubulin was used as 
a loading control and total EGFR, cSrc and AKT was used to rule out that changes in the phosphorylated form was not related 
with differences in the expression of the respective total pair. Results are representative of independent experiments 
performed with CM collected from two different donors and using RKO cells from different cellular passages. 
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cell invasion through the activation of the EGFR pathway. Once more, the slightly 
differences in the ability of macrophage and of Treg-educated macrophages at 2:1 ratio to 
stimulate invasion cannot be explained by the EGFR-mediated signalling pathway.  
 
FoxP3-positive cells infiltrate preferentially at the tumour nest and 
invasive front on human CRC specimens 
Human CRC specimens obtained from a well characterized tissue and tumour data bank 
(Centro Hospitalar do Porto, Hospital de São João) were characterized by IHC for FoxP3+ 
Tregs infiltration at 3 distinct regions, including the adjacent normal colonic mucosa (NCM), 
the tumour invasive front (IF) and the tumour nest (TN), using an anti-FOXP3 antibody 
(Figure 15). For this analysis only cases presenting the three regions within the same 
histological section were considered. The selection didn't have in consideration the patients’ 
clinicopathological data, but the various cancer stages are represented. From the thirty 
specimens analysed, a significantly higher number of FoxP3-positive cells were found at 
both the TN (Non-parametric Mann-Whitney Test; P=0.007) and at the IF (Non-parametric 
Mann-Whitney Test; P=0.0002), comparing with NCM. These results suggest that, although 
not abundant, FoxP3+ cells, most probably Tregs, are preferentially located within the tumour 
and invasive front than in the normal colonic mucosa. This is precisely the region were we 
previously observed more anti-inflammatory macrophages (data not shown), suggesting 
that the immune activity of these populations might be modulated by the existent cancer 
cells or even by FoxP3+ cells. 
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Figure 15. FoxP3–positive cells infiltrate preferentially the tumour nest and invasive front on human CRC specimens. 
a) CRC histologic section with the distinct regions analyzed: adjacent normal colon mucosa (NCM), tumour nest (TN) and 
Invasive front (IF).Immunohistochemically staining of FoxP3, a Treg lineage marker, on one representative case of CRC in the 
b) NCM, c) TN and d) IF. IHC staining of FoxP3 was visualized and counted at 400x magnification. Arrow heads indicate 
brown FoxP3-positive cells.  
 
 
**, significantly different at P<0.01. ***, significantly different at P<0.001. 
  
Marta L. Pinto photograph 
b) NCM 
a 
Table 1. Mean number of FoxP3 in normal colonic mucosa (NCM), tumour nest (TN) and invasive front (IF) from 30 different 
CRC cases. Foxp3=Forkhead box P3; SD=standard deviation. 
c) TN d) IF 
Invasive front Tumour nest 
Normal colonic 
mucosa 
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Discussion 
Tumour-associated macrophages and Tregs dominantly infiltrate tumours but their role on 
CRC fate is controversial. The impact of these immune populations on the regulation of each 
other cell activities and the relevance of such modulation on CRC progression are still to be 
unveiled. Therefore, we investigated the impact of CD4+CD25+ T cell populations on 
macrophage differentiation and the role of CD4+CD25+ Treg-educated macrophages on 
colorectal cancer cell invasion, dissecting the underling pro-invasive mechanisms. With this 
work, we demonstrated that: 1) macrophages alone constitute an heterogeneous population 
whereas, in the presence of CD4+CD25+T cells, macrophage pro-inflammatory phenotype 
was reduced, without achieving a full anti-inflammatory profile; 2) both macrophages and 
CD4+CD25+ T cell-educated macrophages induced RKO cancer cell invasion, being Treg-
educated macrophages at 2:1 ratio the most efficient condition to promote invasion; 3) the 
pro-invasive activity of macrophages and CD4+CD25+ T cell-educated macrophages was 
concomitant with similar increase on pro-MMP9 proteolytic activity; 4) similarly to 
macrophages, CD4+CD25+ T cell-educated macrophages at 2:1 ratio, stimulate cancer cell 
EGFR phosphorylation and 5) FoxP3+ cells accumulated preferentially at the tumour nest 
and at the invasive front than at the normal colonic mucosa of colorectal cancer human 
specimens. 
Activation and differentiation of human monocytes into macrophages can be critically 
affected by culture conditions. Adherence is frequently considered an activation signal for 
monocytes144 and the surface to which monocytes adhere can affect cell survival, 
morphology and ability to form adherent macrophage monolayers145. The seeding of 
monocytes on tissue culture treated polystyrene culture substrates contributed to poor cell 
survival and adherence, whereas polystyrene tissue culture non-treated and glass 
substrates favoured survival and monocyte-derived macrophage differentiation. The slight 
different levels of differentiation between these last conditions can be due to differences in 
cultured cell density: 6-well plates have 0,13 x106 monocytes/cm2 whereas in 24-well plates 
0,26 x106 monocytes/cm2 were seeded, indicating that cells on 24-well plates have the 
possibility to establish more cell-to-cell contacts and to secrete autocrine factors that may 
favour differentiation and adhesion. Monocyte-derived macrophages differentiated, in the 
absence of exogenous stimuli, on 24-well plates with glass coverslips, became elongated 
and exhibited cell protrusions, resembling the in vitro anti-inflammatory like morphology also 
characteristic of non-stimulated heterogeneous macrophage populations146. 
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In humans, regulatory T cells are phenotypically and functionally heterogeneous, but 
no specific cell surface markers have yet been described and their isolation still relies on the 
selection of CD4+CD25high or sorting of CD4+CD25highCD127lowT cells from PBMCs92. In this 
study the limited access to the cell sorter infrastructure led us to rely on the selection of the 
CD4+CD25high population and on its further characterization regarding FoxP3 expression. As 
assessed by FACS, isolation with regulatory T cell isolation kit from StemCell indicated that 
the majority of the isolated population expressed Treg markers. However the presence of a 
small CD4+CD25mid/low T cell population could not be ruled out. The most reasonable 
explanation for this is the lack of defined boundaries between high and intermediated levels 
of CD25 expression cells during the magnetic selection of CD25high cells92, leading to the 
inclusion of activated Tconvs that upregulate the expression of CD25 and FoxP3. Despite 
our reported high levels of FoxP3+ T cells, a very small percentage of 
CD4+CD25mid/highFox3lowCD45RA- non-Tregs and CD4+CD25mid/highFoxP3lowCD45RA+ rTregs 
can also be present92,95. The most rigorous approach to discriminate functional 
CD4+CD25+Treg cells would be to sort this population further combining the cell surface 
marker CD12796, which inversely correlates with intracellular expression of FoxP3, and also 
according to their active or resting state, taking advantage of CD45RA95 and CD15s98 cell 
surface markers. Interestingly, after seven days of culture, the reduced size and irregular 
morphology presented by the CD4+CD25+ T cell population was accompanied by FoxP3 
expression reduction. These results are supported by other reports where long-term cultures 
decreased FoxP3 expression and suppressive properties of former potent Treg suppressor 
cells initially sorted as CD4+CD25highCD45A- T cell population147.  
In addition, our results showed that, in comparison with macrophages and co-
cultures, the isolated CD4+CD25+ T cells display lower ability to reduce resazurin to resorufin 
but cell viability was not affected. This is not unexpected since, besides TCR stimulation by 
anti-CD3, the full activation of Tregs also requires CD28 co-stimulation. Anti-CD28 was not 
added in Tregs mono-cultures based on previous reports describing that macrophage also 
expressed low levels of this receptor148. Therefore, the addition of anti-CD28 to cultures 
could affect macrophage inflammatory profile. Additionally, CD4+CD25+ Treg cells are 
described to be hyporesponsive in vitro, as a result of their high susceptibility to apoptosis 
after activation and suppression95. Alltogether our results indicate that Tregs affected 
macrophage adhesion but not viability or metabolic activity. To further confirm these results 
more accurate viability assays and Tregs activation, by in vitro suppression assays, should 
be performed. The higher metabolic activity in 2:1 ratio, after 7 days of culture, can result 
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from a higher activity from both macrophages and CD4+CD25high T cells. The level of anti-
CD3 and CD28 co-stimulation provided by CD80/CD86 molecules on macrophages was the 
same in 1:1 and 2:1 ratios, however the stimuli per T cell is higher in 2:1 ratio due to the 
lower number of CD4+CD25high T cells, potentiating their activity.  
As expected131, unstimulated macrophages resembled a naïve heterogeneous 
population, expressing both pro- and anti-inflammatory cell surface markers and secreting 
low levels of cytokines. In contrast, along time, CD4+CD25+ Treg-educated macrophages 
decreased CD80, a marker preferentially expressed by pro-inflammatory macrophages.  and 
increased CD163, a marker of anti-inflammatory macrophages. These results suggest that 
CD4+CD25+ T cells induced macrophage polarization towards a more anti-inflammatory 
profile. However, the cytokine profile resembles of an active heterogeneous population with 
high levels of both pro- and anti-inflammatory cytokines. These results must be carefully 
analysed since only one experiment was used to evaluate conditioned medium cytokine 
levels. Nevertheless, these results suggest a pivotal role of CD4+CD25+ T cells in the 
modulation of macrophage towards a more anti-inflammatory-like phenotype. The loss of 
CD80 co-stimulatory molecule observed in co-cultures, represent a well-known mechanism 
of suppression where CTLA-4, highly expressed in Tregs, binds to CD80/CD86 in APCs 
leading to their downregulation, and consequently, affecting Tconvs and APCs cell-cell 
interactions106. In previous work reporting the skewing of monocyte/macrophages by Tregs 
towards an anti-inflammatory profile, the levels of the anti-inflammatory cell surface marker 
CD163 and especially of CD206 were upregulated132. Here, CD163 expression levels are 
still lower than in macrophages mono-culture although increasing along time. These results 
suggest that the increase of CD163 expression in co-cultures is slower than in macrophages 
mono-cultures and/or that this T cell population is not completely skewing macrophages 
towards an anti-inflammatory profile. The CD163 upregulation is dependent on IL-6 and IL-
10 cytokines and is downregulated by IFN-, and TGF-β149,150. Interestingly, in our 
experiments, the levels of tTGF-β were similar in all conditions, suggesting that slight 
differences in CD163 expression were not dependent on this cytokine. These equal levels 
of tTGF-β are expected since the antibodies in tTGF-β ELISA do not permit to discriminate 
between cytokine active and inactive forms. Unexpectedly, the enhanced expression of IL-
6 and the absence of IFN- in our co-cultures were not accompanied by an upregulation of 
CD163. On the other hand, CD4+CD25+ T cell-educated macrophages are described to 
display lower levels of IL-6 and IFN- than macrophages alone132. These results suggest 
that in Treg-macrophage co-cultures CD163 upregulation is associated with other factors, 
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such as IL-10, frequently secreted in these co-cultures. The unexpected high levels of both 
pro- (IL-6) and anti-inflammatory (tTGF-β) molecules obtained can be explained by the 
mixed profile presented by macrophages, secreting both pro- and anti- inflammatory 
cytokines, and/or by the heterogeneous FoxP3+ and FoxP3- T cell populations. One of the 
possible origins for this FoxP3- population are the CD4+CD25-FoxP3low conventional T cells 
that, when freshly isolated expressed CD25mid/low. Upon TCR in vitro stimulation these 
Tconvs are described to present a transient expression of FoxP3, but after long-term in vitro 
culture are able to revert to their conventional T cell phenotype143,151. This population is 
described to produce high levels of both pro- and anti-inflammatory cytokines after co-
culture with monocytes, in comparison with their CD4+CD25+CD127low counterparts131,132. 
Alternatively, but not exclusively, pro-inflammatory cytokines can derive from isolated 
CD4+CD25+FoxP3lowCD45RA- non-Treg cell population or from FoxP3+ aTregs, which 
decreased FoxP3 expression and were induced to produce pro- and anti-inflammatory 
cytokines in co-culture with macrophages95,152. These hypotheses should be confirmed by 
re-purifying macrophages after co-culture and re-assess their inflammatory profile. The 
same procedure should be followed for CD4+ T cells, where the inflammatory profile and the 
immunosuppressive functions of T cells should be assessed. 
Recently, macrophages were described to promote gastric and colorectal cancer cell 
invasion through the release of soluble pro-invasive factors57,58. Although the role of Tregs 
in cancer progression is not clear, based in breast, melanoma and pancreatic mouse cancer 
models, these immune cells seem to have an indirect role in cancer cell metastasis by 
favouring tumour immune evasion and tumour-promoting activities on other immune 
cells117,118. To our knowledge this was the first time that the pro-invasive properties of 
macrophages, differentiated in the presence of CD4+CD25+ T cells, was assessed. We 
showed that, after long-term culture, RKO invasion was promoted by macrophages and by 
CD4+CD25+ T cell-educated macrophages, but not by CD4+CD25+ T cells alone. This 
indicates that CD4+CD25+ T cell have no direct role on RKO cancer cell invasion but that, at 
2:1 ratio, macrophage pro-invasive properties were enhanced. In contrast, SW620 invasion 
was not stimulated. Differences on the basal levels of invasiveness between RKO and 
SW620 cells may be related with intrinsic features of these cell lines. Due to the putative 
indirect role of Tregs and the reported direct role of macrophages on cancer cell invasion 
we sought to search for the underlying pro-invasive mechanisms mediated by macrophages 
on RKO cells. 
FCUP 
Elucidating the role of macrophage and CD4+CD25+ regulatory T cells on colorectal cancer cell invasion
64 
 
Macrophage pro-invasive properties were described to be enhanced in anti-
inflammatory macrophages rather than in their pro-inflammatory counterparts58. We 
hypothesized that, in the presence of Tregs and RKO, macrophages would acquire an anti-
inflammatory profile, explaining their higher pro-invasive activity. Interestingly, Edin and 
collaborators described that macrophages stimulated with M-CSF and supernatant of RKO 
CRC cells, had more similarities with anti-inflammatory macrophages regarding cell surface 
markers while their cytokine secretion profile seemed to be of a “mixed” pro- and anti-
inflammatory population153. Of note, M-CSF-derived macrophages are more active and tend 
to resemble per si an anti-inflammatory profile153. Our experiments are in agreement with 
this study, since CD4+CD25+ T cell-educated macrophages exhibited loss of the pro-
inflammatory CD80 and maintained CD163 anti-inflammatory cell surface receptor. In 
contrast, cytokine expression revealed characteristics of a heterogeneous pro- and anti-
inflammatory profile. mRNA expression pattern of different phenotypic markers as other 
cytokines and chemokines, and additional flow cytometry analysis, involving other cell 
surface receptors should be assessed to further confirm these results. Regarding cancer 
cell secretion profile, RKO did not seem to contribute to the high levels of cytokines detected 
in CD4+CD25+ T- macrophage cultures with RKO. To confirm this, macrophage-CD4+CD25+ 
T co-cultures, without indirect contact with RKO, should be considered in parallel. The limited 
number of isolated CD4+CD25+ T cells impaired this analysis. Importantly, these results also 
highlight that the secretion profile of 1:1 ratio at day 3 was only achieved by 2:1 cultures at 
day 7 (for IL-6, IFN- and TGF-β), indicating that the evolution of co-cultures was dependent 
on the proportion of T cells. Interestingly, IFN-, a factor involved in host defence, was not 
detected in mono- and co-cultures before invasion assay but was highly secreted when 
macrophage-CD4+CD25+ T cells were co-cultured with RKO, suggesting that factors 
produced by the cancer cells primed a pro-inflammatory response. This suggests that naïve 
macrophages could not initiate pro-inflammatory response, within the time points analysed, 
whereas the previous activation of macrophages by CD4+CD25+ T cells may induce a faster 
recognition and response to these factors58. 
The expression and activity of proteolytic enzymes, such as MMPs, have a crucial 
role on the modulation of cancer cell invasion, as they degrade the ECM releasing trapped 
pro-invasive and pro-motile factors, opening paths for cell migration62. MMP2 and MMP9 
proteases are involved in colorectal cancer progression and are produced by macrophages, 
reinforcing their pro-invasive activities57,58,154. In this work only pro-MMP9 seems to explain 
the higher levels of invasion of RKO cells in indirect contact with macrophages and 
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macrophage-CD4+CD25+ T cells cultures. These results are consistent with our previous 
reports indicating that macrophages are major MMP9 producers and that macrophage-
mediated cancer cell invasion was essentially related to MMP9 proteolytic activity19. Since 
CD4+CD25+ T cells and RKO produced low levels of these gelatinases, this study further 
suggests macrophages as the major pro-MMP9 producers and principal proteolysis 
contributors. Although not significant, the levels of pro-MMP9 seem to be higher in co-culture 
than in macrophage mono-cultures, in line with the higher invasive profile obtained in 2:1, 
but not in 1:1 ratio. The differences found between day 3 and 7 may rely on the higher 
immune cell differentiation status but also on the higher activity of MMP9 and MMP2 at day 
7. 
Cancer cells-derived CSF1 recruits and stimulates macrophages to produce EGF, 
which in turn activates cancer cells EGF receptor enhancing their invasion capability and 
motility35. The CFS1-EGF loop was highly described in breast cancer. Additionally, in in vitro 
colon cancer models, macrophage-derived EGF activated cancer cell EGFR 
phosphorylation, stimulating their invasion, motility and migration57. Our results also 
demonstrated that macrophages in mono- and co-cultures induced cancer cell EGFR 
tyrosine residue (Y1086) phosphorylation, a cSrc docking and binding site155. The subsequent 
phosphorylation and activation of cSrc and of AKT were not fully validated. Nevertheless, 
CD4+CD25+ T cell-educated macrophages in 1:1 co-cultures seemed to induce low levels of 
RKO cells cSrc phosphorylation, which suggests that one of the differences between the 
ratios analysed, and respective ability to induce invasion, may underlie on EGFR-pathway 
activation. However, studies in further detail need to be perform to characterize other 
signalling pathways and factors possibly involved in the promotion of cancer cell invasion. 
Of note, the explanation for the different ability of macrophages and of CD4+CD25+ T-
educated macrophages at 2:1 ratio to induce RKO cell invasion remains unclear. These 
findings provide support for the modulatory role of CD4+CD25+ T cells on the modulation of 
the macrophage profile and of the macrophage ability to induce cancer cell invasion and 
EGFR phosphorylation. 
The role of Tregs on colorectal cancer is mostly correlated with favourable 
outcomes121-125. Here we reported that FoxP3-positive cells accumulate preferentially at the 
invasive front and at the tumour nest rather than at the normal colonic mucosa. 
Nevertheless, the reduced number of cases analysed did not allow us to establish any 
relation with patients’ clinicopathological data and to assess their clinical relevance. As 
mentioned above, in humans, FoxP3 can be expressed in non-regulatory T cells or in 
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Tconvs92. Therefore, although FoxP3 is still referenced marker for IHC staining to 
characterize Tregs, the single use of this marker may overestimate their number. In CRC, 
the intratumoural accumulation of FoxP3+ T cells has been correlated with good prognosis. 
The discordant results of Tregs prognosis significance may rely on different Tregs 
subpopulations (rTregs, aTregs, non-Tregs)95 that accumulate at the tumour site. In 
melanoma tissues, higher accumulation of aTregs has been associated with worst 
prognosis156. In this sense, in CRC, the accumulation of non-Tregs cells would be correlated 
with better prognostic129. To further investigate the role of Tregs in CRC, other markers (such 
as CD4, CD25 and/or CD45RA+) should be combined with FoxP3 to assess active and 
resting Tregs infiltration at different tumour regions. Interestingly, our group previously 
observed anti-inflammatory, but not pro-inflammatory, macrophages at the tumour nest and 
invasive front of the same set of CRC specimens (MLPinto, unpublished results). Together 
with our results, we envisage that, in a colorectal cancer context, FoxP3+ T cells and anti-
inflammatory macrophages infiltrate at the same tumour region, interacting and modulating 
each other phenotype and functions. Therefore, the characterization of FoxP3+ T cells 
subpopulations should be crossed with TAMs differentiation profile at the same CRC 
specimen and further correlated with patients’ clinicopathological information. 
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Conclusions and future perspectives 
In conclusion, this work suggests that CD4+CD25+ Tregs were successfully isolated, 
although a small population of CD4+CD25mid/low T cells could not be ruled out. This stands 
out the need for a more rigorous Treg isolation method, for instance sorting this rare and 
heterogeneous population combining more Treg cell surface markers to specifically isolate 
suppressive Tregs from non-Tregs and Tconvs. To further assess Treg purity and function, 
the suppressive ability of Tregs on Tconvs proliferation and cytokine secretion in vitro should 
be investigated. This would allow to highlight the role of highly pure suppressive Treg 
subpopulation on macrophage differentiation. 
Our in vitro co-culture findings provided support for the modulatory role of 
CD4+CD25+ T cells on macrophage morphology, adhesion, inflammatory profile and pro-
invasive properties. CD4+CD25+ Tregs induced macrophage differentiation towards a more 
anti-inflammatory profile despite displaying a “mixed” cytokine secretion. However, these 
results should be further confirmed using quantitative analyses (FACS) of macrophage pro- 
and anti-inflammatory markers. Also, a broader range of cytokines/chemokines and a larger 
sample size should be analysed. Further, CD4+CD25+ T cells do not seem to display direct 
pro-invasive properties but they induced, at the 2:1 ratio, macrophage pro-invasive 
properties. These results were concomitant with an increase of pro-MMP9 proteolytic activity 
and EGFR-phosphorylation on macrophages and on Treg-educated macrophages co-
cultured. However, the distinct role of different CD4+CD25+ T cells ratios on macrophage 
invasion related pathways remains to be elucidated. Nevertheless, it should be emphasized 
that the 2:1 ratio seems to be the most appropriated, since it better reflects the peripheral 
blood macrophage-Treg proportion. The higher ability of CD4+CD25+ T cell-educated 
macrophages, at 2:1 ratio, to induce RKO cell invasion, comparing with macrophage mono-
cultures, should be further analysed. For this, other invasion-related pathways as well as 
factors reported to be involved in the promotion of cancer cell invasion should be examined, 
and a higher number of donors should be considered. In the future, we expect to further 
explore the putative modulatory role of Tregs on macrophage pro-tumoural properties, 
contributing to the design of novel therapeutic strategies targeting macrophages and/or 
Tregs. Of note, our work also demonstrated that FoxP3+ cells accumulate preferentially at 
the intratumoural region and invasive front rather than at the normal colonic mucosa of 
colorectal cancer human specimens. Now, we intent to increase the number of cases 
analysed, further characterize FoxP3+ subpopulations and cross this characterization on 
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CRC specimens with TAMs phenotypic profile and patients’ clinicopathological information, 
to evaluate possible clinical associations. 
 
FCUP 
Elucidating the role of macrophage and CD4+CD25+ regulatory T cells on colorectal cancer cell invasion
69 
 
Supplementary Data 
 
a 
 
 
 
 
 
 
 
 
b 
 
Figure S1. In vitro experimental set-up performed to dissect CD4+CD25+ T-educated macrophages profile and pro-
invasive properties. a) Schematic time-line with methodology applied before or/and after invasion assays to assess cells 
viability, molecular phenotype by immunocytochemistry (ICC), secretion profile by enzyme-linked immunosorbent assays 
(ELISAs) and MMPs activity by zymography. At day 0 b) CD14+ monocytes (Mon) and CD4+CD25+ T cells (CD25+T) were 
isolated and seeded in co-cultures at 1:1 or 2:1 ratios or in single cultures for 3 or 7 days. After this time, RKO or SW620 
human colon cancer cells (CRC cell) were incubated for 24h in the upper compartment of matrigel-coated invasion insert, in 
the presence of: RPMI medium (CRC cell), macrophages (Mac + CRC cell), CD4+CD25+ T cells (CD25+ T + CRC cell), Mac 
and CD4+CD25+ T cells co–cultured at 1:1 or 2:1 ratio (1:1 + CRC cell or 2:1 + CRC cell). 
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